Medical Research Articles Published in June 2012

With a Free Docphin Account, you create a custom list of medical research journal sources that are easy to navigate, search our extensive databse of articles, save and organize your articles into folders, set up alerts to be notificed of research articles that match your interests ... and much more.

Login or Register
06/04/2012
Watch guy overdose on 'bath salts' CNN - Health
06/04/2012
New Melanoma Drugs Beat Chemotherapy in Trials Time - Health
06/04/2012
Study: Childhood Cancer Survivors Face Higher Risk of Breast Cancer Time - Health
06/04/2012
Photos: Trainer Drew Manning's Dramatic Transformation ABC News - Health
06/04/2012
Childhood Cancer Survivors Face New Risks ABC News - Health
06/04/2012
Widely Spaced Letters Help Dyslexic Children Read, Research Shows Wall Street Journal - Health Blog
06/04/2012
Diagnosing The System: Overdose Of Overcare [Book Reviews] Health Affairs
06/04/2012
Foundation Funding In Long-Term Services And Supports [GrantWatch Outcomes] Health Affairs
06/04/2012
First Mention : History of Battle Against Leukemia New York Times - Health
06/04/2012
Well: Really? Always Shave the Patient Before Surgery New York Times - Health
06/04/2012
Richard K. Olney, MD (1947-2012) Neurology
06/04/2012
Spotlight on the June 5 Issue Neurology
06/04/2012
Healthy habits can prevent disease ScienceDaily - Health and Medicine News
06/04/2012
Researchers achieve RNA interference, in a lighter package ScienceDaily - Health and Medicine News
06/04/2012
Vital Signs: Patterns: Fever in Pregnancy Tied to Autism Risk New York Times - Health
06/04/2012
What Makes 'That Loving Feeling'? ABC News - Health
06/04/2012
New Epilepsy Tactic: Fight Inflammation New York Times - Health
06/04/2012
'Good Fat' Stimulated by Cool Temperatures ABC News - Health
06/04/2012
Watch out for bed bugs on vacay CNN - Health
06/04/2012
Abstract 127: miR-141 confers anoikis resistance of ovarian cancer cells by targeting KLF12 Cancer Research
06/04/2012
Abstract 126: miR-221 promotes tumorigenesis in human triple negative breast cancer cells Cancer Research
06/04/2012
Abstract 125: MicroRNA-34a dysregulation promotes tumor growth and tumor angiogenesis in head and neck squamous cell carcinoma Cancer Research
06/04/2012
Abstract 124: Hypoxia-inducible miR-210 is involved in hypoxia-induced cell migration and invasion in human hepatocellular carcinoma Cancer Research
06/04/2012
Abstract 123: DNA methylation of miRNA promoters in breast cancer Cancer Research
06/04/2012
Abstract 122: MiR-9-3 and miR-193a are targets for DNA methylation in non-small cell lung cancers Cancer Research
06/04/2012
Abstract 121: Novel epigenetic mechanisms of resveratrol regulation of PTEN/Akt pathway in prostate cancer Cancer Research
06/04/2012
Abstract 120: Epigenetic silencing of miR-17 and miR-20a in chronic lymphocytic leukemia Cancer Research
06/04/2012
Abstract 119: AR42, a histone deacetylase inhibitor (HDACI), increases microRNA (miR)-29b and sensitizes cells to decitabine (DAC) treatment: A novel epigenetic-targeting approach in acute myeloid leukemia (AML) Cancer Research
06/04/2012
Abstract 118: CTCF, a master epigenetic regulator, is a haploinsufficient tumor suppressor gene in multiple cell lineages Cancer Research
06/04/2012
Abstract 117: The processed pseudogene POU5F1P1in 8q24 is expressed in tumor and shows oncogenicity Cancer Research
06/04/2012
Abstract 116: Targeting hypoxia for the identification of novel biomarkers for prostate cancer Cancer Research
06/04/2012
Depression treatment can prevent adolescent drug abuse ScienceDaily - Health and Medicine News
06/04/2012
How infectious disease may have shaped human origins ScienceDaily - Health and Medicine News
06/04/2012
Zeroing in on the best shape for cancer-fighting nanoparticles ScienceDaily - Health and Medicine News
06/04/2012
Hands-on research: Neuroscientists show how brain responds to sensual caress ScienceDaily - Health and Medicine News
06/04/2012
Cancer drugs: Better, cheaper ScienceDaily - Health and Medicine News
06/04/2012
‘Good fat’ activated by cold, not ephedrine ScienceDaily - Health and Medicine News
06/04/2012
U.S. Has Drug Recall Problem, Study Says ABC News - Health
06/04/2012
Heart Attack Hustle: Cutting Treatment Times ABC News - Health
06/04/2012
Letters: Overly Aggressive Care (2 Letters) New York Times - Health
06/04/2012
Letters: A Very Expensive Nap (2 Letters) New York Times - Health
06/04/2012
U.S. Hospitals Adding Palliative Care Teams at a Feverish Pace Time - Health
06/04/2012
Live Chat: Sleep Better Together Wall Street Journal - Health Blog
06/04/2012
Essay: Urging Doctors to ‘Do Less’ May Fall on Deaf Ears New York Times - Health
06/04/2012
Watch: World With Less Pain: Caregiver's Perspective ABC News - Health
06/04/2012
Watch: Drug Recalls: A Growing Problem In the U.S. ABC News - Health
06/04/2012
Cancer Doctors Say Some, Not All, Drug Shortages Have Eased Wall Street Journal - Health Blog
06/04/2012
Global Update: Giving Zinc to Seriously Ill Infants Appears to Save Lives New York Times - Health
06/04/2012
Cannabinoid shown effective as adjuvant analgesic for cancer pain ScienceDaily - Health and Medicine News
06/04/2012
Will a NYC supersize soda ban help obesity battle? ScienceDaily - Health and Medicine News
06/04/2012
High blood caffeine levels in older adults linked to avoidance of Alzheimer’s disease ScienceDaily - Health and Medicine News
06/04/2012
Ignoring vaccinations could get tougher CNN - Health
06/04/2012
Watch out for bed bugs on vacay CNN - Health
06/04/2012
Vaccinations of US children declined after publication of now-refuted autism risk ScienceDaily - Health and Medicine News
06/04/2012
Abstract 115: KIR haplotype polymorphism determines innate susceptibility/resistance to childhood leukemia Cancer Research
06/04/2012
Abstract 114: Study of the high-grade ovarian cancer precursors in the oviduct Cancer Research
06/04/2012
Abstract 113: Effect of targeting Aurora kinase A in human oral squamous cell carcinoma cells Cancer Research
06/04/2012
Abstract 112: An endogenous mTOR inhibitor, PRAS40, is upregulated in lung cancer and contributes to tumor cell invasion and chemoresistance Cancer Research
06/04/2012
Abstract 111: PIK3R1 gene alterations, insights on its role in lung cancer Cancer Research
06/04/2012
Abstract 110: Role of CARD 10 mediated NF-kB activation in colorectal carcinoma cells Cancer Research
06/04/2012
Abstract 109: CSE1L, a 20q gain passenger that drives colorectal adenoma to carcinoma progression Cancer Research
06/04/2012
Abstract 108: Functional characterization of WAC, a candidate tumor suppressor gene in colorectal cancer Cancer Research
06/04/2012
Abstract 107: p53 mutation at codon 273 in colorectal cancer and colitis-derived ALDHhigh cells promotes sphere formation in vitro Cancer Research
06/04/2012
Abstract 106: Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers Cancer Research
06/04/2012
Abstract 105: Characterizing the exomic profile of MSI colorectal cancer Cancer Research
06/04/2012
Abstract 104: New liver cancer genes identified by lentiviral vector-based insertional mutagenesis in mice are associated to differential survival in hepatocellular carcinoma patients Cancer Research
06/04/2012
Abstract 103: DCPS as a cutaneous squamous cell carcinoma susceptibility gene Cancer Research
06/04/2012
Abstract 102: Functional characterization of long noncoding RNA SPRY4-IT1 in human melanomas Cancer Research
06/04/2012
Abstract 101: Analysis of GNAQ mutations in subtypes of malignant melanoma Cancer Research
06/04/2012
Abstract 100: Somatic mutations in Pyk2 in melanoma alter protein activity, interactions and localization Cancer Research
06/04/2012
Abstract 99: Posttranslational modification of the RBBP6 isoform 3 is required for excessive cell proliferation Cancer Research
06/04/2012
Abstract 96: From genome-wide association studies (GWAS) to functional genomics of prostate cancer: exploring the role of candidate transcripts through RNAi-based analysis Cancer Research
06/04/2012
Abstract 94: Epigenetic silencing of CDO1 sustains viability of breast cancer cells via the reduction of cellular ROS Cancer Research
06/04/2012
Abstract 93: Defining the roles of COIL and WIPI1 in breast cancer metastasis Cancer Research
06/04/2012
Abstract 92: Odonogenic Ameloblast Associated Protein (ODAM) moderates cell growth and invasion in the human breast cancer line MDA-MB-231 in part through the TGF-{beta} signaling pathway Cancer Research
06/04/2012
Abstract 91: The CUL4A ubiquitin ligase, a putative target gene at the 13q34 amplicon and its role in breast cancer pathogenesis & progression Cancer Research
06/04/2012
Abstract 90: An evaluation of the genes involved in the Base Excision Repair (BER) pathway as potential phenotypic modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Research
06/04/2012
Abstract 89: Osteopontin-c and osteopontin-b splicing isoforms activate prostate cancer progression features Cancer Research
06/04/2012
Abstract 88: Stabilizing but not activating {beta}-catenin by E-cad/CTF2 Cancer Research
06/04/2012
Abstract 87: Micropapillary breast carcinoma is characterized by deregulation of genes involved in cell division control Cancer Research
06/04/2012
Abstract 86: Inhibition of oncogenic Pim kinases, including Pim-2, alters cell growth and signaling in pancreatic cancer Cancer Research
06/04/2012
Abstract 85: RUNX1 and ELK1 directly regulate the transcription of EVI1 during megakaryocytic differentiation Cancer Research
06/04/2012
Abstract 84: Evidence supporting a role of FKBP51 in melanoma pathogenesis Cancer Research
06/04/2012
Abstract 83: Differential regulation of PTEN in ER{alpha} positive and negative ovarian cancer cells during cisplatin induced apoptosis Cancer Research
06/04/2012
Abstract 82: Novel role of DAPK-1 in growth regulation of ER-negative breast cancer Cancer Research
06/04/2012
Abstract 81: Role of GRM1 in breast cancer Cancer Research
06/04/2012
Abstract 80: Differential expression of NILCO reveals pathogenesis of human breast cancer Cancer Research
06/04/2012
Abstract 79: The role of BRCA1 and SUMO in ubiquitination of cyclinb1 Cancer Research
06/04/2012
Abstract 78: BRCA1/2 mutation analysis in 43 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation Cancer Research
06/04/2012
Abstract 77: Study of the effect of MAPRE2 on human lung adenocarcinoma cell migration and invasion Cancer Research
06/04/2012
Abstract 75: Identification and characterization of novel MELK (maternal embryonic leucine zipper kinase) substrates in breast cancer cells Cancer Research
06/04/2012
Abstract 74: The role of epithelial splicing regulatory protein 1 in ovarian cancer Cancer Research
06/04/2012
Abstract 73: The transfection of high mobility group protein AT-hook 1 (HMGA1) is associated with the development of androgen independency in prostate cancer cells Cancer Research
06/04/2012
Abstract 72: Amino terminus of SEPT9_i1 impacts cellular localization: Implications for mammary tumorigenesis Cancer Research
06/04/2012
Abstract 71: Mutational analysis for IDH1 and IDH2 in pediatric leukemia Cancer Research
06/04/2012
Abstract 70: Loss of cellular senescence checkpoint functions reveals the oncogene characteristics of Notch1 in squamous cell carcinomas Cancer Research
06/04/2012
Abstract 69: Genomic deletions clustered on chromosomes 8 and 9 are associated with pancreatic cancer progression Cancer Research
06/04/2012
Abstract 68: Evaluation of BRCA1 mutations in patients with triple negative breast cancer Cancer Research
06/04/2012
Abstract 67: Characterization of the role of KLF9 transcription factor in breast cancer estrogen response Cancer Research
06/04/2012
Abstract 66: Inhibition of glioma cell proliferation and tumor development by Sox21 Cancer Research
06/04/2012
Abstract 65: Rationally designed peptidomimetics target androgen receptor signaling in prostate cancer Cancer Research
06/04/2012
Abstract 64: Identification of novel kinases involved in Estrogen receptor-{alpha} (ER{alpha}) signalling and the development of endocrine resistance in breast cancer Cancer Research
06/04/2012
Abstract 63: Id4 acts as a tumor suppressor by inducing apoptosis and sensitizing prostate cancer cells to chemotherapeutic agent doxorubicin Cancer Research
06/04/2012
Abstract 62: Vitamin D3 induces 15-Hydroxyprostaglandin Dehydrogenase to suppress pancreatic cancer cell proliferation Cancer Research
06/04/2012
Abstract 61: A new serotype chimera Cancer Terminator Virus (Ad.5/3-CTV) expands the efficiency and specificity of prostate cancer gene transfer and therapy Cancer Research
06/04/2012
Abstract 60: KLF5 deletion promotes but does not initiate prostate carcinogenesis Cancer Research
06/04/2012
Abstract 59: Effects of Cdc42 overexpression on the developing mammary gland Cancer Research
06/04/2012
Abstract 58: Comparative determination of compound delivery to orthotopic and subcutaneous tumors by non-invasive imaging Cancer Research
06/04/2012
Abstract 57: Adipocyte oxidative stress promotes epithelial-mesenchymal transition (EMT) related gene expression and estrogen receptor (ER) negative phenotype in breast cancer cells Cancer Research
06/04/2012
Abstract 56: Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis through upregulated TAGLN expression Cancer Research
06/04/2012
Abstract 55: Further characterization of the human myoma tissue organotypic invasion assay Cancer Research
06/04/2012
Abstract 54: Cancer-associated fibroblasts induce epithelial-mesenchymal-transition and stemness in non-small-cell lung cancer Cancer Research
06/04/2012
Abstract 53: Tumor-associated macrophage promotes oral cancer progression through activation of Axl signal pathway Cancer Research
06/04/2012
Abstract 52: Gene expression profiling of breast cancer associated fibroblasts and their adjacent counterparts Cancer Research
06/04/2012
Abstract 51: Stromal AKT2 controls epithelial invasions Cancer Research
06/04/2012
Abstract 50: Abrogation of stromal TGF-{beta} signaling induces DNA damage and genetic/epigenetic alterations in neighboring epithelia Cancer Research
06/04/2012
Abstract 49: Targeting the TNF network in human ovarian cancer - A systems biology approach Cancer Research
06/04/2012
Abstract 48: Activation of c-Met receptor signaling by carcinoma-associated fibroblasts in the tumor microenvironment Cancer Research
06/04/2012
Abstract 47: Cancer-associated fibroblasts mediate extracellular matrix remodeling and three-dimensional invasion of scirrhous gastric carcinoma cells Cancer Research
06/04/2012
Abstract 46: Microglial stimulation of glioblastoma invasion involves EGFR and CSF-1R signaling Cancer Research
06/04/2012
Abstract 45: The clinical significance of CD163 in patients with hepatocellular carcinoma who underwent curative resection Cancer Research
06/04/2012
Abstract 44: Enhancement endometrial cancer cells malignant transformation by mutual interaction with mesenchymal stem cells through TGF-beta and SDF-1 signaling pathways Cancer Research
06/04/2012
Abstract 42: Expression of interleukin-7 and its signalling intermediates in human neuroblastoma tumours. Cancer Research
06/04/2012
Abstract 41: Identification of CXCL5/ENA-78 regulating the interaction of cholangiocarcinoma and cancer-associated fibroblasts Cancer Research
06/04/2012
Abstract 40: Targeting MLCK expression in cancer-associated fibroblasts disrupts tumor-stromal interactions in gastric cancer Cancer Research
06/04/2012
Abstract 39: Mir-21 regulates TGF-{beta}1-induced CAF formation through Smad7 Cancer Research
06/04/2012
Abstract 981: SRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-kB/STAT3 complex to its promoter in malignant lymphoid cells Cancer Research
06/04/2012
Abstract 979: The anti-tumor activity of the Smoothened inhibitor IPI-926 in models of residual disease is time dependent Cancer Research
06/04/2012
Abstract 978: Inhibition of Polo-like kinase 1 as a strategy in the treatment of adrenocortical carcinoma Cancer Research
06/04/2012
Abstract 977: Elevated MDM2 protein contributes to activity of MDM2 antagonists by enabling p53 induction of antitumor microRNAs Cancer Research
06/04/2012
Abstract 975: Employing functional genomics to reveal emergent dependencies Cancer Research
06/04/2012
Abstract 972: Direct activation of pro-apoptotic BAX as a novel strategy for cancer therapy Cancer Research
06/04/2012
Abstract 971: Identification of BCL6 targeted therapies for breast cancer through gene expression networks Cancer Research
06/04/2012
Abstract 970: Multi-layer and integrative analysis of the whole transcriptome in Asian gastric cancer: AMPK{beta} modulation in cancer progression Cancer Research
06/04/2012
Abstract 969: Amplifications, gene fusions, and therapeutic targets in triple negative and refractory ER+ and HER2+ breast cancers Cancer Research
06/04/2012
Abstract 968: Molecular and clinical correlates of PTEN expression in melanoma Cancer Research
06/04/2012
Abstract 966: Predictive biomarkers of the AKT inhibitor, GDC-0068, in single agent and combination studies Cancer Research
06/04/2012
Abstract 964: Intra-tumor heterogeneity and Darwinian selection revealed by multi-region exome sequencing of renal cell carcinomas Cancer Research
06/04/2012
Abstract 962: Multiplexed mutational profiling of breast tumor as an efficient clinical tool for personalized breast cancer treatment Cancer Research
06/04/2012
Abstract 961: Pathways of tumorigenesis promoted by the growth factor progranulin in SW-13 adrenocortical carcinoma cells Cancer Research
06/04/2012
Abstract 960: Intratumoral dihydrotestosterone regulation by conversion of androstanediol to dihydrotestosterone in prostate cancer Cancer Research
06/04/2012
Abstract 959: ER{alpha}1 represses breast cancer EMT by inhibiting EGFR-mediated downregulation of E-cadherin Cancer Research
06/04/2012
Abstract 958: PELP1 regulation of mTOR Axis: Role in breast cancer progression and resistance Cancer Research
06/04/2012
Abstract 957: TMPRSS2:ERG overexpression limits vitamin D receptor action in prostate cancer cells Cancer Research
06/04/2012
Abstract 956: The liver-X-receptor-{alpha} is involved in the induction by Tamoxifen of breast cancer cell differentiation and death Cancer Research
06/04/2012
Abstract 955: Role of cMYC as a critical determinant of estrogen-independent growth of estrogen deprivation-resistant breast cancer cells Cancer Research
06/04/2012
Abstract 954: COX-2 inhibition reduces bone tumor growth in animal models:A role for celecoxib treatment in cAMP/protein kinase A-induced tumors Cancer Research
06/04/2012
Abstract 953: Therapeutic significance of estrogen receptor <= agonists in gliomas Cancer Research
06/04/2012
Abstract 951: Preclinical evaluation of Xanthohumol in carcinoid cancer growth in vitro and in vivo Cancer Research
06/04/2012
Abstract 950: Orphan nuclear receptor DAX1 exhibits suppressive effect on prostate cancer cell growth Cancer Research
06/04/2012
Abstract 949: Disruption of growth hormone signaling improves the efficacy of conventional chemotherapy in a rat model of mammary cancer Cancer Research
06/04/2012
Abstract 948: IGF-I receptor expression is associated with stage and has therapeutic activity in human biliary tract cancers Cancer Research
06/04/2012
Abstract 946: Discovery of a novel benzotriazole-type retinoid X receptor partial-agonist decreasing plasma glucose level in type-2 diabetes mellitus with decreased side effects Cancer Research
06/04/2012
Abstract 943: Characterization of RET and integrin signaling in thyroid tumors Cancer Research
06/04/2012
Abstract 941: Suppression of the androgen receptor function by c-Jun in prostate cancer via a dual mechanism Cancer Research
06/04/2012
Abstract 940: Inhibition of androgen receptor activity in refractory prostate cancer cells by the novel Millennium-Takeda compound T-1759243 Cancer Research
06/04/2012
Abstract 938: Metabolomic analysis on pharmacological responses to oxaliplatin plus 5-FU in colorectal cancer cells Cancer Research
06/04/2012
Abstract 937: Dose-banding of docetaxel in MT-3 tumor bearing nude mice Cancer Research
06/04/2012
Abstract 936: Nonclinical safety and pharmacology of VX15/2503: a humanized IgG4 monoclonal antibody to SEMA4D Cancer Research
06/04/2012
Abstract 935: Lapatinib and other tyrosine kinase inhibitors greatly potentiate doxorubicin-induced damage to cardiac myocytes Cancer Research
06/04/2012
Abstract 934: Electrophysiological, behavioural and molecular characterization of the neuropathic pain in bortezomib-induced peripheral neuropathy Cancer Research
06/04/2012
Abstract 932: Selective requirement of BH3-only proteins for apoptosis induced by targeted therapies in colon cancer cells and xenografts Cancer Research
06/04/2012
Abstract 930: p38 MAPK is required for the antitumor activity of the vascular disrupting agent DMXAA Cancer Research
06/04/2012
Abstract 924: In vitro study of the potential antineoplastic effect of synthetic naphthoquinones in cisplatin-resistant ovarian cancer lineage Cancer Research
06/04/2012
Abstract 923: Interrelations between roles of phospholipase C-gamma 1 inhibition, mTOR and glycolytic enzymes in growth and survival of glioblastoma cells Cancer Research
06/04/2012
Abstract 922: ABTL0812: A new drug class with oral antitumor action inhibiting mTOR activity and DHFR expression Cancer Research
06/04/2012
Abstract 921: Liposomal bortezomib improves chemosensitivity and inhibits cell proliferation in part through BCR/ABL downregulation in CML Cancer Research
06/04/2012
Abstract 920: Effective elimination of drug resistsant melanoma cells by {alpha}-phenylethyl isothiocyanate (PEITC) Cancer Research
06/04/2012
Abstract 919: Design and preclinical pharmacological evaluation of a cleavable succinate ester solubilizing group for isoindolinone MDM2-p53 protein-protein interaction inhibitors Cancer Research
06/04/2012
Abstract 916A: Cancer cell proliferation is inhibited by specific modulation frequencies Cancer Research
06/04/2012
Abstract 914: Ciclopirox olamine (CPX) inhibits breast cancer cell proliferation by blocking the formation of a PEAK1-Src-eIF5a protein complex Cancer Research
06/04/2012
Abstract 911: Vemurafenib FDG-PET preclinical imaging outcomes across BRAF V600E mutant and resistant tumors Cancer Research
06/04/2012
Abstract 905: Mirk/Dyrk1B mediates cell survival and G0/G1 phase of cell cycle via interacting with MAPK/ERK pathway in human cancer cells Cancer Research
06/04/2012
Abstract 903: The IKK{alpha} kinase is a potential therapeutic target in K-Ras-induced lung cancer Cancer Research
06/04/2012
Abstract 901: Mitotic kinase inhibitors synergize with PI3K and Akt inhibitors in a novel model of anaplastic thyroid carcinomas Cancer Research
06/04/2012
Abstract 900: Caveolin-1 silencing arrests the proliferation of glioblastoma cells by inhibition of STAT3 signalling Cancer Research
06/04/2012
Abstract 899: Development of Hedgehog acyltransferase antagonists as a novel way to inhibit Shh signaling in pancreatic cancer Cancer Research
06/04/2012
Abstract 896: Enhancing mTOR targeted therapy in bladder cancer Cancer Research
06/04/2012
Abstract 895: Quantitative drug sensitivity and resistance testing (DSRT) of primary ex vivo AML blasts highlights mTOR and MEK as potential key molecular driver signals of therapeutic significance Cancer Research
06/04/2012
Abstract 894: Targeting ROS1 receptor tyrosine kinase gene fusions in non-small cell lung cancer Cancer Research
06/04/2012
Abstract 893: Anticancer effect and mechanism of prostaglandin E2 receptor EP4 antagonist Cancer Research
06/04/2012
Abstract 892: Angiotensin II /angiotensin II type I receptor (AGTR1) promotes cell growth in epithelial ovarian cancer Cancer Research
06/04/2012
Abstract 891: The chemokine receptor CXCR7 transduces its signal through mTOR: the role of everolimus Cancer Research
06/04/2012
Abstract 890: Interleukin 11: A novel therapeutic target in IL-11R{alpha} expressing sarcomas Cancer Research
06/04/2012
Abstract 887: Development of a robust nanoimmunoassay and immunohistochemical assay for asparagine synthetase Cancer Research
06/04/2012
Abstract 884: Basonuclin1 (BNC1): A novel therapeutic target in ovarian cancer identified through integrative TCGA-based functional genomic analysis Cancer Research
06/04/2012
Abstract 883: Cell-based selection of RNA-aptamers to specifically target glioblastoma cancer stem cells Cancer Research
06/04/2012
Abstract 882: Genomics approach to identify drug transporter ABCF1 associated with liver cancer recurrence and chemo-resistance Cancer Research
06/04/2012
Abstract 881: Leveraging the molecular heterogeneity of patient-derived tumor samples to simulate clinical trial settings and model combination treatments Cancer Research
06/04/2012
Abstract 877: Identification of novel genes critical to survival of MPNST cells via medium throughput screening using lentiviral shRNA Cancer Research
06/04/2012
Abstract 876: Viability screens in leukemic and breast cancer cells with pooled lentiviral shRNA libraries identify potential therapeutic targets and synergistic lethal interactions Cancer Research
06/04/2012
Abstract 873: Combined targeting of Akt and MEK with the Akt inhibitor GDC-0068 and MEK inhibitor GDC-0973 demonstrates synergistic anti-tumor effects Cancer Research
06/04/2012
Abstract 872: Identification of romidepsin (FK228) and its analogs as HDAC/PI3K dual inhibitors Cancer Research
06/04/2012
Abstract 871: Dual inhibition of PI3K and Erk1/2 shows synergy and efficacy in human tumor cells, either by using drug combinations or novel dual PI3K/Erk inhibitors Cancer Research
06/04/2012
Abstract 870: Synergistic antitumor activity of AKT inhibitor MK2206 and FUS1-nanoparticles in LKB1 mutant NSCLC Cancer Research
06/04/2012
Abstract 869: Potent in vitro and in vivo anti-tumor activity of PI3K inhibitor BAY 80-6946 and MEK inhibitor BAY 86-9766 in preclinical biliary tract cancer models Cancer Research
06/04/2012
Abstract 861: Selective small-molecule kinase inhibitors of the c-Src:FAK complex Cancer Research
06/04/2012
Abstract 860: The multi-targeted kinase inhibitor Sunitinib induces apoptosis in colon cancer cells via PUMA Cancer Research
06/04/2012
Abstract 859: CDK11 (PITSLRE) kinase expression is critical for human cancer cell growth and proliferation Cancer Research
06/04/2012
Abstract 856: Biomarkers of sensitivity and resistance to the BTK inhibitor PCI-32765 in mantle cell lymphoma Cancer Research
06/04/2012
Abstract 854: Patient stratification strategies for NVP-BGJ398, a selective pan-FGFR inhibitor in phase I clinical trials Cancer Research
06/04/2012
Abstract 852: ARRY-380, a potent, small molecule inhibitor of ErbB2, increases survival in intracranial ErbB2+ xenograft models in mice Cancer Research
06/04/2012
Abstract 850: Activation of autophagy by erlotinib protects NSCLC cells with wild-type EGFR from erlotinib cytotoxicity Cancer Research
06/04/2012
Abstract 849: Cabozantinib (XL184) inhibits growth of prostate cancer in the bone and results in an altered bone environment Cancer Research
06/04/2012
Abstract 846: Targeted inhibition of c-Met receptor by a selective c-Met inhibitor, Tivantinib, and a specific shRNA reduces breast cancer-derived bone metastases Cancer Research
06/04/2012
Abstract 845: In vitro and in vivo pharmacology of SAR125844, a potent and selective intravenous MET kinase inhibitor undergoing Phase I clinical trial Cancer Research
06/04/2012
Abstract 843: Influx of thiosemicarbazone NSC73306 is mediated by the cisplatin and copper transporter SLC31A1 (CTR1) Cancer Research
06/04/2012
Abstract 842: Proteomics-based comparative analysis of mitochondria isolated from human cisplatin-sensitive and resistant ovarian carcinoma cell lines Cancer Research
06/04/2012
Abstract 841: CCL2 and interleukin-6 regulate EMT-mediated chemo-resistance in prostate cancer Cancer Research
06/04/2012
Abstract 840: High levels of hexadeca-4,7,10,13-tetraenoic acid (16:4(n-3)) in fish oil induce resistance to chemotherapy in vivo Cancer Research
06/04/2012
Abstract 839: Chemotherapeutic sensitization of drug-resistant lung cancer cells by doxorubicin and leptomycin B Cancer Research
06/04/2012
Abstract 838: A metabolomic analysis revealed the involvement of deoxycytidine kinase and CTP synthase in the sensitivity of human pancreatic cancer cells to gemcitabine Cancer Research
06/04/2012
Abstract 836: Insulin-like growth factor-I receptor (IGF-IR) dowregulation in cisplatin-resistant human ovarian cancer cells Cancer Research
06/04/2012
Abstract 835: Epigenetic biomarkers of chemoresistance in colorectal cancer Cancer Research
06/04/2012
Abstract 833: The CXXC motifs in the metal binding domains are required for ATP7B to mediate resistance to cisplatin Cancer Research
06/04/2012
Abstract 832: Suicide gene therapy is effective for treating chemo-resistant small cell lung cancer cells Cancer Research
06/04/2012
Abstract 831: Increased resistance of breast cancer cells to doxorubicin by clinically relevant doses of temsirolimus Cancer Research
06/04/2012
Abstract 830: Insulin-like growth factor binding protein-2 and chemosensitivity in esophageal adenocarcinoma Cancer Research
06/04/2012
Abstract 829: Down-regulation of insulin-like growth factor-binding protein 7 in cisplatin-resistant non-small cell lung cancer Cancer Research
06/04/2012
Abstract 38: The role of autocrine epidermal growth factor receptor (EGFR) signaling in breast cancer metastasis Cancer Research
06/04/2012
Abstract 37: CCN6 downregulation in invasive breast carcinomas: In situ characterization of changes in EMT proteins and metastatic disease Cancer Research
06/04/2012
Abstract 36: The Importance of sticking together; Cdh1 loss in the gastric zymogenic lineage Cancer Research
06/04/2012
Abstract 35: Breast cancer cell interactions Cancer Research
06/04/2012
Abstract 34: Inhibitory effects of betulinic acid isolated from Nelumbo nucifera (Lotus) on breast cancer-mediated bone destruction Cancer Research
06/04/2012
Abstract 33: Implementing CAD cells quantify the relationships between Ig-CAM-mediated adhesion, force transduction, and actin dynamics Cancer Research
06/04/2012
Abstract 32: P190B RhoGAP overexpression drives mammary epithelial cell proliferation by altering stromal-epithelial interactions in the developing mammary gland Cancer Research
06/04/2012
Abstract 31: Activated phosphatidylinositol-3 kinase: An oncogene that increases gap junctional, intercellular communication Cancer Research
06/04/2012
Abstract 30: The integrin {alpha}6A splice variant regulates colon cancer cell proliferation and the Wnt/{beta}-catenin pathway Cancer Research
06/04/2012
Abstract 29: Functional analysis of PAX8 in high-grade serous ovarian cancer Cancer Research
06/04/2012
Abstract 28: The Netrin-1 receptor UNC5C is a tumor suppressor in colorectal malignancies Cancer Research
06/04/2012
Abstract 27: Chemotherapy-induced Akt survival signaling is regulated by CD44- Ezrin/Radaxin Moesin (ERM) scaffolding, dependent on EGFR activity Cancer Research
06/04/2012
Abstract 26: Deletion of Slc5a8 in mice promotes metabolic syndrome, colonic inflammation, and colon cancer: A phenomenon dependent on dietary fiber content Cancer Research
06/04/2012
Abstract 25: CBL enhances breast tumor formation by inhibiting tumor suppressive activity of TGF-beta signaling Cancer Research
06/04/2012
Abstract 24: Role of S100A14 in proliferation and invasion of oral cancer-derived cells Cancer Research
06/04/2012
Abstract 23: Sensitivity of EGFR exon 20 insertion mutations to EGFR inhibitors is determined by their location within the tyrosine kinase domain of EGFR Cancer Research
06/04/2012
Abstract 22: Differential IGF-II response of AA and CA normal breast cell lines to prolactin treatment Cancer Research
06/04/2012
Abstract 21: Gastrokine 1 functions as a tumor suppressor by regulating inflammatory mediators Cancer Research
06/04/2012
Abstract 20: PHLDA1/2 contribute to tumor suppression in breast and lung cancer as downstream targets of oncogenic HER2 signaling Cancer Research
06/04/2012
Abstract 19: Desmoplakin has a tumor suppressive function through inhibition of Wnt/{beta}-catenin signalling pathway in human lung cancer Cancer Research
06/04/2012
Abstract 18: Slc5a8 inactivation is associated with mammary gland involution delay, early onset of mammary tumorigenesis and accelerated lung metastasis Cancer Research
06/04/2012
Abstract 17: Tumor-suppressive function of SLC5A8 in renal cancer cells Cancer Research
06/04/2012
Abstract 16: Downregulation of CYLD leads to acquisition of mesenchymal state and increased migration via ligand-independent TGF{beta}R1 activation in human oral squamous cell carcinoma cells Cancer Research
06/04/2012
Abstract 15: Inhibition of IGF-1 suppress genomic instability and epithelial lineage aberrations in the mammary gland of BRCA1 deficient mice Cancer Research
06/04/2012
Abstract 14: CCN6 knockdown-induced epithelial to mesenchymal transition and invasion is mediated through upregulation of TGF{beta} type III receptor Cancer Research
06/04/2012
Abstract 13: Expression of mutant c-KIT isoforms in fibroblasts causes tumorigenic transformation Cancer Research
06/04/2012
Abstract 12: Bcr/Abl induces expression of Aurora kinase A via Akt signaling Cancer Research
06/04/2012
Abstract 11: A requirement for SOCS-1 and SOCS-3 phosphorylation in BCR-ABL-mediated transformation Cancer Research
06/04/2012
Abstract 10: Oncogenic variant EGFRvIII defines a hierarchy in glioblastoma and expression is restricted by epigenetic mechanisms despite the presence of gene amplification Cancer Research
06/04/2012
Abstract 9: Imbalanced oncogenic signaling: Analogies between structurally distinct EGFR mutants of relevance to lung and brain cancers Cancer Research
06/04/2012
Abstract 8: Genomic analyses of heterogeneous HER2 3+ invasive ductal carcinomas of the breast Cancer Research
06/04/2012
Abstract 7: Knockdown of EGFR to investigate its therapeutic potential for treatment of non-small cell lung cancers Cancer Research
06/04/2012
Abstract 6: Investigating the functional significance of FGFR2 SNP status in breast cancer Cancer Research
06/04/2012
Abstract 5: Frequency of FGFR2 gene amplification in gastric cancer Cancer Research
06/04/2012
Abstract 4: Gene amplification of EGFR, HER2, HER3 and HER4 in esophageal squamous cell carcinoma Cancer Research
06/04/2012
Abstract 3: HER2 gene-amplified human breast cancer cells harboring a gatekeeper T768M mutation in HER2 overexpress EGFR ligands and are sensitive to dual therapeutic blockade of EGFR and HER2 Cancer Research
06/04/2012
Abstract 2: FGFR3 as a therapeutic target in squamous cell lung carcinoma Cancer Research
06/04/2012
Abstract 1: Oncogenic extracellular domain mutations of ERBB2 in cancer Cancer Research
06/04/2012
Abstract 995: Transient low doses of DNA demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells Cancer Research
06/04/2012
Abstract 994: Colorectal cancer, adenoma and normal whole genome methylation sequencing in Africa Americans Cancer Research
06/04/2012
Abstract 993: A high-throughput peptide array screen of H3K9 methyl effectors identifies UHRF1 as an exception to the "phospho/methyl switch." Cancer Research
06/04/2012
Abstract 992: Credentialing UHRF1 as a target for prostate cancer therapy Cancer Research
06/04/2012
Abstract 991: The DNA methylome of castration-resistant prostate cancer Cancer Research
06/04/2012
Abstract 990: Nucleosome occupancy at unmethylated promoter CpG islands represents a novel mechanism of epigenetic gene silencing in cancer Cancer Research
06/04/2012
Abstract 989: The crosstalk of mTOR/S6K1 and Hedgehog pathways Cancer Research
06/04/2012
Abstract 988: Oncogenic PI3K mutations lead to NF-{kappa}B-dependent cytokine expression following growth factor deprivation Cancer Research
06/04/2012
Abstract 987: Overexpression of 14-3-3{alpha} in cancer cells activates PI3K via binding the p85 regulatory subunit Cancer Research
06/04/2012
Abstract 986: Reverse-engineered, forward-simulation of MEK-dependent molecular networks reveal novel regulators of cell cycle and cancer cell survival Cancer Research
06/04/2012
Abstract 985: Dissecting PI3K-AKT pathway by phosphoproteomic profiling of PIK3CA knock-in mutants Cancer Research
06/04/2012
Abstract 984: High-level expression of YAP induces protumorigenic Notch signalling in human hepatocarcinogenesis Cancer Research
06/04/2012
Abstract 983: Wnt pathway activation involves inhibition of {beta}-catenin ubiquitination within the endogenous Axin1 complex Cancer Research
06/04/2012
Abstract 585: Eicosapentaenoic acid increases mammary tumor inhibition of intermittent calorie restriction and regulates adipokines Cancer Research
06/04/2012
Abstract 584: Vitamin D suppresses pro-inflammatory cytokines and microRNAs in 3D prostatic co-cultures Cancer Research
06/04/2012
Abstract 583: Physiological concentrations of genistein reduced ER-{alpha} promoter methylation and increased ER-{alpha} expression in prostate cancer cells Cancer Research
06/04/2012
Abstract 582: Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage, and is associated with inhibition of estrogen-induced breast cancer Cancer Research
06/04/2012
Abstract 580: Combined treatment of breast cancer cells with epigallocatechin gallate (EGCG) and Tamoxifen delays cell-growth in long-term culture: Implications for recurrent breast cancer Cancer Research
06/04/2012
Abstract 579: 3, 3'-diindolylmethane enhances the effectiveness of Herceptin by upregulation of miR-200 through down-regulation of FoxM1 in breast cancer cells Cancer Research
06/04/2012
Abstract 578: Apigenin blocks medroxyprogesterone acetate-dependent progression of BT-474 human breast tumor xenografts by inducing apoptosis Cancer Research
06/04/2012
Abstract 577: Equol enhances tamoxifen's antitumor effect by induction of caspase-mediated apoptosis in MCF-7 breast cancer cells Cancer Research
06/04/2012
Abstract 576: Novel compounds from Allspice (Pimenta dioica) inhibit breast cancer growth by autophagy induction Cancer Research
06/04/2012
Abstract 575: Correlation of serum vitamin D levels and changes in breast density Cancer Research
06/04/2012
Abstract 574: {alpha}-santalol induces caspase-dependent apoptosis and G2/M phase cell cycle arrest in human breast cancer cells Cancer Research
06/04/2012
Abstract 573: Deguelin inhibits the expression of estrogen receptor alpha in human breast cancer cells Cancer Research
06/04/2012
Abstract 572: Induction of NAD(P)H-Quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer Cancer Research
06/04/2012
Abstract 571: Prevention of breast cancer by delaying promotion and progression Cancer Research
06/04/2012
Abstract 570: Breast cancer chemopreventive activity of a novel amide derivative of sulindac involves inhibition of PDE5, activation of PKG, and attenuation of Wnt/{beta}-catenin signaling Cancer Research
06/04/2012
Abstract 569: Targeting inflammatory pathways as an effective therapeutic approach to suppress tumorigenicity and prevent metastasis in inflammatory breast cancer Cancer Research
06/04/2012
Abstract 568: Biomarkers of phenethyl isothiocyanate-mediated mammary cancer prevention in MMTV-neu mouse model Cancer Research
06/04/2012
Abstract 565: Benzyl isothiocyanate-mediated inhibition of epithelial-mesenchymal transition in human breast cancer cells is associated with downregulation of urokinase-type plasminogen activator and its receptor Cancer Research
06/04/2012
Abstract 564: Bim-independent apoptosis by benzyl isothiocyanate in human breast cancer cells is mediated by PUMA Cancer Research
06/04/2012
Abstract 563: Chemoprevention of mammary cancer in MMTV-neu transgenic mice by dietary administration of cruciferous vegetable constituent phenethyl isothiocyanate Cancer Research
06/04/2012
Abstract 562: Targeting TMEPAI in breast cancer therapy and prevention Cancer Research
06/04/2012
Abstract 561: Role of nucleolin in activation of NF-{kappa}B signaling with Tip<=, a carcinogenic factor of H. pylori Cancer Research
06/04/2012
Abstract 560: Development of an organotypic raft culture system to study the role of latent membrane protein 1 during Epstein-Barr virus replication Cancer Research
06/04/2012
Abstract 558: Bortezomib induction of the unfolded protein response mediates Epstein-Barr virus lytic activation but is separable from bortezomib-induced cytotoxicity Cancer Research
06/04/2012
Abstract 556: L-Tag-driven systemic immune regulatory profile as a potential signature for polyomavirus BK involvement in prostate cancer Cancer Research
06/04/2012
Abstract 555: A role for XMRV in prostate tumor promotion in vivo Cancer Research
06/04/2012
Abstract 554: Qualification of a p16INK4A immunohistochemistry (IHC) assay for determination of HPV status in archival Squamous Cell Carcinoma of the Head and Neck (SCCHN) formalin fixed paraffin embedded (FFPE) specimens from a randomized phase 3 trial Cancer Research
06/04/2012
Abstract 553: High prevalence of human papilloma virus in esophageal squamous cell carcinoma: A preliminary study Cancer Research
06/04/2012
Abstract 552: Characterization of HPV infection in Hispanic colorectal cancer patients Cancer Research
06/04/2012
Abstract 551: Human papillomavirus (HPV) infection characteristics in a cohort of men who have sex with men (MSM) during long-term follow-up Cancer Research
06/04/2012
Abstract 550: Increased risk of persistent human papillomavirus infection and abnormal Pap tests in African American compared to European American women in a college-age cohort Cancer Research
06/04/2012
Abstract 547: Mapping of estrogen receptor-dependent and independent signaling pathways for xeno- and phytoestrogens Cancer Research
06/04/2012
Abstract 545: Autocrine growth regulation by PEDF is mediated by ovarian steroid hormones: Implications in the pathogenesis of endometrial carcinoma Cancer Research
06/04/2012
Abstract 541: Cadmium activates translationally controlled tumor protein (TCTP) and p38 MAPK as possible pathways for prostate cancer cell aggressiveness Cancer Research
06/04/2012
Abstract 540: Increased growth and malignant transformation of human prostate epithelial cells by chronic exposure to arsenic and estrogen Cancer Research
06/04/2012
Abstract 538: ROS differentially regulates prostate cancer cell survival Cancer Research
06/04/2012
Abstract 537: Alcohol exposure in utero induces histophysiological changes in prostate and increases susceptibility to prostate tumorigenesis in rat offspring Cancer Research
06/04/2012
Abstract 535: The role of high mobility group box 1 (HMGB1) in prostate carcinogenesis Cancer Research
06/04/2012
Abstract 533: Dendritic cells are professional educators of Natural Killer cells Cancer Research
06/04/2012
Abstract 532: Nod1 functions in T cells to suppress inflammation-associated colorectal cancer Cancer Research
06/04/2012
Abstract 531: Human {gamma}{delta} T cells limit breast tumor growth partly by down regulating cell survival-related molecules and up regulating apoptosis-related molecules in tumor cells Cancer Research
06/04/2012
Abstract 529: Impaired NF-{kappa}B signaling in myeloid cells enhances urethane-induced lung carcinogenesis Cancer Research
06/04/2012
Abstract 528: Preventing perioperative cancer metastases formation by enhancing Natural Killer cell activity Cancer Research
06/04/2012
Abstract 526: Cancer immunoediting by the innate immune system in the absence of adaptive immunity Cancer Research
06/04/2012
Abstract 525: Toll-like receptor-4 mediated cutaneous immune responses augment ultraviolet radiation-induced DNA damage and tumor development Cancer Research
06/04/2012
Abstract 524: Cytokine therapy by allogenic IFN-alpha-expressing murine colorectal cancer cells suppresses outgrowth of established tumors in a murine hepatocellular carcinoma model Cancer Research
06/04/2012
Abstract 523: {gamma}{alpha} T cells are activated by protein-bound polysaccharide krestin (PSK) and contribute to the antitumor effect of PSK Cancer Research
06/04/2012
Abstract 522: Cooperative effect of the TLR3-agonist Poly(A:U) combined to a Smac-mimetic against malignant nasopharyngeal carcinomas cells Cancer Research
06/04/2012
Abstract 521: 4, 4'-Dichlorodiphenyltrichloroethane (DDT) and Triclosan (TCS) decrease tumor-cell-binding capacity and cell-surface protein expression of human natural killer cells Cancer Research
06/04/2012
Abstract 520: Regulation of natural killer cell development and antitumor immunity by the IL-15 system Cancer Research
06/04/2012
Abstract 518: Immunogenicity of cancer/testis antigen XAGE-1d in patients with non-small cell lung cancer (NSCLC) Cancer Research
06/04/2012
Abstract 517: Anti-glycan IgM and IgG antibodies as new biomarkers for serous ovarian cancers Cancer Research
06/04/2012
Abstract 516: Obinutuzumab (GA101): A novel type II glycoengineered CD20 antibody exhibits enhanced cell death against Rituximab-resistant and -sensitive cell lines in B-cell non-Hodgkin lymphoma Cancer Research
06/04/2012
Abstract 515: Generation of MAGE-C2/CT10-specific T cell clones for immunotherapy of multiple myeloma Cancer Research
06/04/2012
Abstract 514: Relationship between loss of heterozygosity of HLA-A gene and HLA class I expression in gastric cancer Cancer Research
06/04/2012
Abstract 513: Novel monoclonal antibody detects an intracellular portion of the MUC16 in ovarian carcinoma Cancer Research
06/04/2012
Abstract 512: Leukemia-specific immunity in healthy individuals and patients post-transplant targets phosphorylated tumor antigens Cancer Research
06/04/2012
Abstract 511: Characterization of humoral response profiles of ovarian cancer patients as diagnostic biomarkers Cancer Research
06/04/2012
Abstract 510: Identification and characterization of immunogenic epitopes from CD133 and their potential for use to immunologically target cancer stem cells Cancer Research
06/04/2012
Abstract 509: Immunoglobulin reactivity analysis of chronic lymphocytic leukemia patients unveils Lymphocyte Cytosolic Protein 1 (LCP1) as a novel CLL exosome antigen Cancer Research
06/04/2012
Abstract 505: Jagged 2 knockdown inhibits invasion in colorectal cancer cell lines Cancer Research
06/04/2012
Abstract 504: Metformin potently inhibits cell proliferation, adhesion and invasion in ovarian cancer cells Cancer Research
06/04/2012
Abstract 503: Investigating the role of Tks5 and invadopodia in prostate tumor progression Cancer Research
06/04/2012
Abstract 502: Schwann cells promote tumor cell invasion through regulation of the laminin receptorA6B1 Cancer Research
06/04/2012
Abstract 501: The carboxypeptidase inhibitor TIG1 interacts with cathepsin L2 and inhibits cathepsin L2-stimulated cellular invasion Cancer Research
06/04/2012
Abstract 500: DMP1 activates osteolytic cycle in a tumor environment Cancer Research
06/04/2012
Abstract 499: NFATc1 is a novel invasion promoter in colorectal cancer Cancer Research
06/04/2012
Abstract 496: Isolation and characterization of a highly invasive subpopulation from MDA-MB-231 breast cancer cells Cancer Research
06/04/2012
Abstract 495: Overexpression of TIS21/BTG2/PC3 inhibits formation of invadopodia in the highly metastatic breast cancer cells MDA-MB-231 Cancer Research
06/04/2012
Abstract 494: Proteolysis of pseudokinase PTK7 controls cancer cell invasion Cancer Research
06/04/2012
Abstract 493: Endothelin-1 induces activation of vascular endothelial growth factor receptor-3 and modulates cell migration and vasculogenic mimicry in melanoma cells Cancer Research
06/04/2012
Abstract 492: Identification of a novel complex MUC1/CIN85 involved in invasion and migration of breast cancer cells Cancer Research
06/04/2012
Abstract 491: Endoglin suppresses prostate cancer invasion through two distinct type II TGF-{beta} receptors Cancer Research
06/04/2012
Abstract 489: Micro-RNA signature of glioblastoma multiforme invasion: An in vivo study in patient-tumor derived orthotopic xenograft mouse models Cancer Research
06/04/2012
Abstract 488: Investigating the molecular mechanisms of tumor cell invasion Cancer Research
06/04/2012
Abstract 486A: Biological characterization of recombinant maspin in breast cancer cells Cancer Research
06/04/2012
Abstract 486: The novel tumor suppressor DIAPH3 governs transition to an amoeboid phenotype Cancer Research
06/04/2012
Abstract 484: A role for mDia formins in epithelial ovarian cancer spheroid invasion Cancer Research
06/04/2012
Abstract 483: Serine phosphorylation of vasodilator-stimulated phosphoprotein defines the malignant cell phenotype in colon cancer Cancer Research
06/04/2012
Abstract 482: Comparison of the actin-binding proteins actinin-1 and actinin-4: Their role in cancer Cancer Research
06/04/2012
Abstract 480: Psoriasin (S100A7) regulates epidermal growth factor signaling and actin polymerization in estrogen receptor positive breast cancer cells Cancer Research
06/04/2012
Abstract 479: The effects of sarcophine-diol (SD) on melanoma B16F10 cell line Cancer Research
06/04/2012
Abstract 476: The effects of the synthetic triterpenoid acetylenic tricyclic bis-(cyano enone) on cell migration and epithelial-to-mesenchymal transition Cancer Research
06/04/2012
Abstract 475: uPAR and cathepsin B knockdown inhibits radiation-induced PKC integrated integrin signaling to the cytoskeleton and migration of glioma initiating cells Cancer Research
06/04/2012
Abstract 474: The essential role of Gi{alpha}2 in prostate cancer progression Cancer Research
06/04/2012
Abstract 473: Elevated cAMP decreases migratory potential in pancreatic cancer cells Cancer Research
06/04/2012
Abstract 472: Nek3 kinase in breast cancer pathogenesis: The role of paxillin phosphorylation Cancer Research
06/04/2012
Abstract 471: Acute activation of beta2-adrenergic receptor inhibits in vitro renal carcinoma cell migration through betaArrestin2-mediated regulation of p115RhoGEF Cancer Research
06/04/2012
Abstract 469: CD151 and cell motility in prostate cancer Cancer Research
06/04/2012
Abstract 468: 70kDa fibronectin splice variant induced human mammary fibroblast migration Cancer Research
06/04/2012
Abstract 467: Mitochondrial dynamics regulates migration and invasion of breast cancer cells Cancer Research
06/04/2012
Abstract 466: Synthetic triterpenoids target cell migration and cell adhesion via GSK3{beta} Cancer Research
06/04/2012
Abstract 465: NEDD9 adaptor protein in glioblastoma cell migration and invasion Cancer Research
06/04/2012
Abstract 463: MAP4K4 (HGK) plays a key role in tumor progression Cancer Research
06/04/2012
Abstract 461: Involvement of {alpha}9{beta}1 integrin-iNOS pathway in matrix metalloproteinase-9 and/or urokinase plasminogen activator receptor-mediated glioma cell migration Cancer Research
06/04/2012
Abstract 460: The role of Cdc42 in cancer cell perineural invasion Cancer Research
06/04/2012
Abstract 456: The Alpha9 nicotinic acetylcholine receptor is the key mediator In nicotine-enhanced cancer metastasis in breast cancer cells Cancer Research
06/04/2012
Abstract 454: Glucocorticoids enhance metastatsis and tumorigenicity in a triple negative breast cancer cell line Cancer Research
06/04/2012
Abstract 450: Smad interacting protein 1 (SIP1) is associated with peritoneal carcinomatosis in intestinal type gastric cancer Cancer Research
06/04/2012
Abstract 449: Detection of some selected tumor markers in people from River Nile State - Sudan Cancer Research
06/04/2012
Abstract 448: Expression of Glypican-3 (GPC3) in breast cancer tumors from Brazilian and Argentinean patients Cancer Research
06/04/2012
Abstract 447: Has the expression of the Wnt-pathway in regard to cMYC and {beta}-Catenin a predicitive influence on the kind of metastasis in colon cancer Cancer Research
06/04/2012
Abstract 446: Protein kinase Ciota is a new prognostic factor in gastric cancer Cancer Research
06/04/2012
Abstract 445: Has k-Ras predictive influence on the kind of metastasis in patients with colon carcinoma Cancer Research
06/04/2012
Abstract 443: Expression of the RECK tumor and metastasis suppressor gene in human breast cancer: a poor prognosis marker Cancer Research
06/04/2012
Abstract 442: Increased miR-let7c level indicates transition from localized bladder cancer to metastasis Cancer Research
06/04/2012
Abstract 440: Wnt signaling regulates neuropilin-2 (NRP2) expression and contributes to cancer cell invasiveness in castration-resistant prostate cancer (CRPC) Cancer Research
06/04/2012
Abstract 439: Glycosylation of {alpha}-dystroglycan in prostate cancer: Prognostic implications and regulation by LARGE2 Cancer Research
06/04/2012
Abstract 438: The importance of estrogen-ER{beta} axis in racial disparity of prostate cancer Cancer Research
06/04/2012
Abstract 436: Resistance to fluid shear stress is a conserved novel biophysical property of malignant cells Cancer Research
06/04/2012
Abstract 435: Targeted exome sequencing to understand tumor progression and identify targeted therapies Cancer Research
06/04/2012
Abstract 434: Identification of 14-3-3{alpha} as a predictor of early time to recurrence and a molecular target in metastatic hormone receptor-positive and -negative breast cancers Cancer Research
06/04/2012
Abstract 433: Expression of stem cell and EMT markers on circulating tumor cells Cancer Research
06/04/2012
Abstract 432: Differences in molecular background of colorectal liver and lung metastases Cancer Research
06/04/2012
Abstract 431: ErbB4 is a novel driver of metastasis and anoikis resistance in Ewing's sarcoma Cancer Research
06/04/2012
Abstract 429: The high mobility group A1 oncogene enhances cellular reprogramming to a pluripotent stem-like cell Cancer Research
06/04/2012
Abstract 428: Post-translational phosphorylation is essential for nanog-mediated tumorigenesis Cancer Research
06/04/2012
Abstract 426: Sox2 expression in breast cancer stem cells: Possible mechanisms Cancer Research
06/04/2012
Abstract 425: Targeting embryonic signaling pathways in melanoma Cancer Research
06/04/2012
Abstract 424: Amplification of OCT4-pseudogene POU5F1B is a poor prognostic factor in gastric cancer Cancer Research
06/04/2012
Abstract 423: SENP1 regulates OCT4 under hypoxia: effect of its sumoylation on protein stability and drug susceptibility of human pluripotent germ cell tumors Cancer Research
06/04/2012
Abstract 422: Nanog promotes PI3K/Akt and mTOR-mediated invasion in head and neck squamous cell carcinoma Cancer Research
06/04/2012
Abstract 421: Deciphering the molecular mechanisms behind Oct4(hi) tumor-initiating breast cancer cells with global gene expression Cancer Research
06/04/2012
Abstract 420: Physiological {beta}-catenin signaling regulates pluripotency genes in cancer microcell hybrids Cancer Research
06/04/2012
Abstract 418: Development and characterization of cancer stem cell model from mouse iPS cells Cancer Research
06/04/2012
Abstract 417: Inflammation initiates OCT4/NANOG expression through IL-6-IGF-1R signaling activation and is associated with early recurrence of HBV-related HCC Cancer Research
06/04/2012
Abstract 789: GSTP1 expression is regulated by MycN and is a marker of poor outcome in childhood neuroblastoma Cancer Research
06/04/2012
Abstract 788: CK2{alpha} regulates MRP1 mediated multidrug drug resistance in cancer via phosphorylation of Thr249 Cancer Research
06/04/2012
Abstract 787: Involvement of HER2, HIF-1, and BCRP in cancer stem cell characteristics of letrozole-resistant breast cancer cells Cancer Research
06/04/2012
Abstract 786: In-vivo and in-vitro breast cancer profiling to delineate adaptive endocrine resistance: A pilot study Cancer Research
06/04/2012
Abstract 785: Leptin-Notch-Wnt axis affects drug resistance in breast cancer Cancer Research
06/04/2012
Abstract 784A: Profiling pancreatic cancer metabolism and tumor microenvironment for therapy Cancer Research
06/04/2012
Abstract 784: Synergistic effect of magnetic nanoparticles and docetaxel on prostate cancer cells in vitro Cancer Research
06/04/2012
Abstract 783: Combination treatment with epigallocatechin-3-gallate and sulforaphane sensitize ovarian cancer cells to cisplatin Cancer Research
06/04/2012
Abstract 781: The effect of vorinostat on the development of resistance to doxorubicin in neuroblastoma Cancer Research
06/04/2012
Abstract 780: An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells Cancer Research
06/04/2012
Abstract 779: Prodrug-mediated reversal of multidrug resistance in breast cancer cells Cancer Research
06/04/2012
Abstract 778: HER2 as therapeutic target for overcoming ATP-binding cassette transporter-mediated chemoresistance in small cell lung cancer Cancer Research
06/04/2012
Abstract 777: GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance Cancer Research
06/04/2012
Abstract 776: Sensitization of glioblastoma cells to temozolomide induced antitumor effect by PLGA-aspirin microsphere through modulation of {beta}-catenin transactivation Cancer Research
06/04/2012
Abstract 775: Targeting the transcriptional coactivator LEDGF/p75 to overcome chemoresistance in prostate cancer Cancer Research
06/04/2012
Abstract 772: Notch1 affects ABCC1-mediated drug efflux and drug sensitivity in MCF7 breast cancer cells Cancer Research
06/04/2012
Abstract 770: Overcoming Trastuzumab resistance with the novel pan-erbb inhibitor AZD8931 Cancer Research
06/04/2012
Abstract 769: Restoration of c-Cbl function, by inhibiting Cdc42, confers tamoxifen sensitivity on basal-like (triple negative) breast cancer cells Cancer Research
06/04/2012
Abstract 768: MCL1 and glycolysis synergistically induce prednisolone resistance, which can be therapeutically reversed Cancer Research
06/04/2012
Abstract 766: Galiximab disrupts the dysregulated NF-{kappa}B/YY1/Snail/BclXL circuit that regulates the resistance of B-NHL cell lines: Sensitization to chemo-immunotherapeutic drugs Cancer Research
06/04/2012
Abstract 765: Growth rates of tumors with numerous histologies remain constant while patients are on therapy Cancer Research
06/04/2012
Abstract 763: A phase 1 open-label study to investigate the potential drug-drug interaction (DDI) between single-dose (SD) dacomitinib (PF-00299804; DC) and steady-state (SS) paroxetine (PX) in healthy volunteers (HVs) Cancer Research
06/04/2012
Abstract 762: Therapeutic drug monitoring of Anthracyclines and Taxanes in chemotherapy of breast cancer patients Cancer Research
06/04/2012
Abstract 761: Phase I interaction study of docetaxel with supplementation of St. John's wort Cancer Research
06/04/2012
Abstract 760: A randomized, crossover, phase 1 study to evaluate the effect of a strong CYP3A4 inhibitor on tivantinib (ARQ 197) pharmacokinetics in healthy subjects Cancer Research
06/04/2012
Abstract 758: Comparative pharmacokinetics for 4-demethyl-4-cholesteryloxy- carbonylpenclomedine (DM-CHOC-PEN) in humans Cancer Research
06/04/2012
Abstract 757: Development and validation of an HPLC-UV method for lapatinib quantification in human plasma Cancer Research
06/04/2012
Abstract 756: Pharmacokinetics of curcumin and curcumin O-glucuronide in healthy volunteers characterized by liquid chromatography-tandem mass spectrometry Cancer Research
06/04/2012
Abstract 754: The effect of CC chemokine ligand-2 (CCL2/MCP-1) and CC chemokine ligand-5 (CCL5/RANTES) on the pharmacokinetics (PK) and the pharmacodynamics (PD) of pegylated liposomal CKD602 (S-CKD602) in patients with advanced solid tumors Cancer Research
06/04/2012
Abstract 753: Pharmacokinetic profile of the base-excision repair inhibitor methoxyamine-HCl (TRC102; MX) given as an one-hour intravenous infusion with temozolomide (TMZ) in the first in human phase 1 clinical trial Cancer Research
06/04/2012
Abstract 751: Mass balance, excretion and metabolism of [14C] ASA404 in cancer patients in a phase I trial Cancer Research
06/04/2012
Abstract 750: Impairment of clofarabine (CLO) clearance (CL) in the presence of cimetidine: Evidence of a drug-drug interaction between clofarabine and inhibitors of human organic cation transporter-2 (hOCT2) Cancer Research
06/04/2012
Abstract 749: A Phase I, open-label study investigating the disposition of [14C]-cabazitaxel in patients with advanced solid tumors Cancer Research
06/04/2012
Abstract 747: Absorption, distribution, metabolism, and excretion of 14C-Labeled tivantinib (ARQ 197) in healthy male subjects Cancer Research
06/04/2012
Abstract 746: Notch-1 expression in human cancer cell lines and solid tumors by validated immunohistochemistry Cancer Research
06/04/2012
Abstract 744: Testing the carcinogenic potential of water disinfectant byproducts in a human colon mucosal culture system Cancer Research
06/04/2012
Abstract 741: Sunitinib plus hormone ablation and radiation therapy for patients with high-risk localized prostate cancer: Results from a multi-institutional phase I study Cancer Research
06/04/2012
Abstract 740: PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy: A study in a Swedish rectal cancer trial of preoperative radiotherapy Cancer Research
06/04/2012
Abstract 739: Increased mortality in patients with pituitary adenomas Cancer Research
06/04/2012
Abstract 738: Re-irradiation for recurrent malignant glioma by boron neutron capture therapy Cancer Research
06/04/2012
Abstract 737: Hypofractionated stereotactic radiotherapy to surgical cavity after resection for brain metastasis Cancer Research
06/04/2012
Abstract 735: Metaplastic columnar lined esophagus without goblet cells show phenotypic similarities to Barrett's Esophagus Cancer Research
06/04/2012
Abstract 733: Clinicopathological significance of CXCL12/CXCR4 expression in esophageal squamous cell carcinoma Cancer Research
06/04/2012
Abstract 732: Overexpression of the basic helix-loop-helix protein DEC1 induces cellular senescence and is related to better survival in esophageal squamous cell carcinoma Cancer Research
06/04/2012
Abstract 729: Plasma EBV DNA concentration and clearance rate as good prognostic factors for metastatic nasopharyngeal carcinoma Cancer Research
06/04/2012
Abstract 728: CXCL12 (SDF-1) chemokine expression as a baseline factor associated with resistance to induction chemotherapy in head and neck squamous cell carcinoma Cancer Research
06/04/2012
Abstract 727: Homozygosity for Arg of p53 codon 72 correlates with poor prognosis in Puerto Rican patients with head and neck squamous cell carcinoma Cancer Research
06/04/2012
Abstract 726: Copy number amplification of the PIK3CA gene is associated with poor prognosis in early-stage head and neck squamous cell carcinoma Cancer Research
06/04/2012
Abstract 724: Gene expression in clinically normal oral mucosa of oral cancer patients facilitates identification of markers predictive of OSCC outcomes Cancer Research
06/04/2012
Abstract 723: Detection of TIMP3 promoter hypermethylation in salivary rinse as an independent predictor of local recurrence-free survival in head and neck cancer Cancer Research
06/04/2012
Abstract 722: Significance of p16 in site-specific HPV-positive and HPV-negative HNSCC Cancer Research
06/04/2012
Abstract 721: Expression of Aurora A and Phospho-Aurora-A is predictive of survival in patients with head and neck cancer Cancer Research
06/04/2012
Abstract 716: High viral load is associated with poor postoperative survival in hepatitis B virus-related hepatocellular carcinoma Cancer Research
06/04/2012
Abstract 714: Survivin expression in patients with resected pancreatic adenocarcinoma Cancer Research
06/04/2012
Abstract 710: Genetic identification of Annexin-A8 as a therapeutic target and prognostic marker for pancreatic cancer Cancer Research
06/04/2012
Abstract 709: Angiogenic switch: novel therapeutic target for pancreatic cancer Cancer Research
06/04/2012
Abstract 708: Clinical significance of insulin-like growth factor 1 receptor (IGF1R) expression in pancreatic cancer Cancer Research
06/04/2012
Abstract 707: CD133 is a useful surrogate marker to predict chemosensitivity of neoadjuvant chemotherapy for breast cancer Cancer Research
06/04/2012
Abstract 705: HER2 assessment to define outcomes for breast cancer patients treated with neoadjuvant therapy Cancer Research
06/04/2012
Abstract 704: Expression of FOXO1 is associated with GATA3 and Annexin-1 and predicts disease-free survival in breast cancer Cancer Research
06/04/2012
Abstract 703: Verification of a novel approach to identify disease mechanisms in breast cancer patient subsets and application of this approach to indicating and characterizing tamoxifen resistance Cancer Research
06/04/2012
Abstract 701: TUMOR lymphocyte infiltration, expression of CD4, CD8, FOXP3, CD34 molecules and their relationship with tumor evolution after primary treatment in breast cancer patients Cancer Research
06/04/2012
Abstract 700: Reduced CYLD expression is an independent prognostic factor in breast cancer: A possible link with RANKL-RANK signaling Cancer Research
06/04/2012
Abstract 699: The prognostic value of DNA polymerase <= for breast cancers Cancer Research
06/04/2012
Abstract 698: Overexpression of the aryl hydrocarbon receptor correlates with high tumor grade in human breast invasive carcinomas Cancer Research
06/04/2012
Abstract 697: Clinical and prognostic comparison between triple-negative and non-triple-negative breast cancer Cancer Research
06/04/2012
Abstract 695: Significant loss of nuclear expression of Actinin-4 in metastatic breast carcinoma and lymph nodes: A novel biomarker for metastatic breast carcinoma Cancer Research
06/04/2012
Abstract 689: Validation of antibodies to Estrogen Receptor <= and quantitative assessment of ER{alpha}1 and ER{alpha}5 expression in breast cancer Cancer Research
06/04/2012
Abstract 688: Lamin A/C a novel potential prognostic marker in early operable primary breast cancer Cancer Research
06/04/2012
Abstract 684: Identification of biomarker genes associated with endocrine therapy responsiveness in patients with estrogen receptor positive IBC and nIBC Cancer Research
06/04/2012
Abstract 682: Increased stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients Cancer Research
06/04/2012
Abstract 680: Loss of miR-34a as measured by quantitative in situ hybridization on a tissue microarray is associated with poor outcome in breast cancer Cancer Research
06/04/2012
Abstract 679: Retrospective evaluation of the BRCA1 - PARP pathway in breast cancer tissues Cancer Research
06/04/2012
Abstract 676: Serological levels of folate at birth and risk of childhood acute lymphoblastic leukemia Cancer Research
06/04/2012
Abstract 674: A pilot study of physical activity and breast cancer risk in Africa Cancer Research
06/04/2012
Abstract 673: Obesity, weight gain, physical activity and polymorphism in mTOR pathway and risk of renal cell carcinoma Cancer Research
06/04/2012
Abstract 671: Smoking, alcohol consumption and body size measures and risk of B-cell non-Hodgkin lymphoma among women in Los Angeles Cancer Research
06/04/2012
Abstract 670: Cigarette smoking, race, and genetic ancestry in association with plasma vitamin D-binding protein (VDBP) in healthy African Americans (AA) and Caucasian Americans (CA) Cancer Research
06/04/2012
Abstract 669: Disparities in head and neck cancer: A case for chemoprevention with vitamin D Cancer Research
06/04/2012
Abstract 668: History of diabetes mellitus as a risk factor for pancreatic cancer: The Iowa Women's Health study Cancer Research
06/04/2012
Abstract 666: The effect of comorbidity, smoking and alcohol on survival of head and neck cancer anatomic subsites: A retrospective analysis of 4689 patients Cancer Research
06/04/2012
Abstract 664: Menthol cigarettes in relation to breast cancer incidence in African American women Cancer Research
06/04/2012
Abstract 663: Circulating lipids and fatty acids and non-Hodgkin lymphoma risk in a nested case-control study: The Multiethnic Cohort Cancer Research
06/04/2012
Abstract 662: Effect of tobacco smoking on the risks of childhood acute lymphocytic and myeloid leukemias, by phenotypic and cytogenetic subtype Cancer Research
06/04/2012
Abstract 660: Dairy foods and nutrients in relation to risk of epithelial ovarian cancer Cancer Research
06/04/2012
Abstract 658: Fruit and vegetable intake and cancer incidence in Korean men Cancer Research
06/04/2012
Abstract 657: Perinatal factors and breast cancer risk: The CECILE study Cancer Research
06/04/2012
Abstract 656: Clinical profiles predict early non-adherence to adjuvant endocrine treatment in a prospective breast cancer cohort Cancer Research
06/04/2012
Abstract 655: Menopausal hormone therapy and breast cancer risk: The CECILE Study Cancer Research
06/04/2012
Abstract 653: Passive smoking facilitate the risk of CIN1 in high risk HPV-positive women: Korean HPV Cohort Study Cancer Research
06/04/2012
Abstract 652: Reproductive and hormonal factors and ovarian cancer: Case-control study Cancer Research
06/04/2012
Abstract 649: Anthropometric factors and breast cancer among African American women participating in the Women's Circle of Health Study Cancer Research
06/04/2012
Abstract 647: Use of statin and risk of prostate cancer recurrence among patients who received radical prostatectomy Cancer Research
06/04/2012
Abstract 646: Soy food intake and risk of lung cancer: Evidence from the Shanghai Women's Health Study and a meta-analysis Cancer Research
06/04/2012
Abstract 645: Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by anatomic site and lesion severity Cancer Research
06/04/2012
Abstract 643: Vitamin D deficiency increases breast cancer risk: A population based case-control study in the Chinese population Cancer Research
06/04/2012
Abstract 642: Body fat distribution and prostate cancer risk: A UK case-control study Cancer Research
06/04/2012
Abstract 640: Age of menarche and height as adolescent growth in relation to breast cancer risk Cancer Research
06/04/2012
Abstract 639: The effect of grapefruit intake on endogenous serum estrogen levels in postmenopausal women Cancer Research
06/04/2012
Abstract 637: Dietary heme iron and risk of colorectal cancer with specific mutations in colorectal cancer key genes Cancer Research
06/04/2012
Abstract 635: Indoor tanning and risk of early-onset basal cell carcinoma Cancer Research
06/04/2012
Abstract 633: Synergistic interplay between long-term overweight and long menstrual years in endometrial cancer Cancer Research
06/04/2012
Abstract 632: Effect of body mass index on the association between smoking and risk of gastric cancer in the Singapore Chinese Health Study Cancer Research
06/04/2012
Abstract 630: Tobacco smoking women are not at higher risk than men for lung cancer Cancer Research
06/04/2012
Abstract 628: Prospective cohort studies of vitamin B6 intake and colorectal cancer incidence: Modification by time Cancer Research
06/04/2012
Abstract 626: Dietary glycemic load, glycemic index and risk of primary liver cancer: Results from the Shanghai women's and men's health studies Cancer Research
06/04/2012
Abstract 625: Flavonoid intake and risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study Cohort Cancer Research
06/04/2012
Abstract 624: Areca users in combination with tobacco and alcohol use are associated with younger age of diagnosed esophageal cancer in Taiwanese men Cancer Research
06/04/2012
Abstract 622: Estrogen plus progesterone and colorectal cancer incidence and mortality in the Women's Health Initiative Cancer Research
06/04/2012
Abstract 621: The importance of antioxidant, antiangiogenesis and immune stimulation in cancer Cancer Research
06/04/2012
Abstract 618: Rhodiola rosea L. extract, SHR-5, and metformin exhibit potent activity against bladder carcinogenesis in the UPII-mutant Ha-ras transgenic model. Cancer Research
06/04/2012
Abstract 617: Apigenin intake regulates Fox 'O' signaling in an autochthonous mouse model of prostate cancer Cancer Research
06/04/2012
Abstract 616: A cumulative molecular model for the mechanisms of green tea catechins in the chemoprevention of prostate cancer Cancer Research
06/04/2012
Abstract 615: Apigenin regulates prostate cancer matrix composition and cell attachment through an integrin alpha 1 dependent pathway Cancer Research
06/04/2012
Abstract 614: Increased oxidative DNA damage in human prostate cancer and its relationship to GSTP1 expression Cancer Research
06/04/2012
Abstract 613: Synergistic antiproliferative activity of combined administration of atorvastatin and zoledronic acid in LNCaP and PC3 prostate cancer cells Cancer Research
06/04/2012
Abstract 612: Fisetin, a dietary flavonoid and novel mTOR inhibitor for treatment and prevention of prostate cancer Cancer Research
06/04/2012
Abstract 611: Alpha-santalol, a chemopreventive agent induces apoptosis in human prostate cancer cells by causing caspase-3 activation Cancer Research
06/04/2012
Abstract 610: The role of oxidative stress in the growth inhibitory and proapoptotic effects of brown button mushrooms (Agaricus bisporus) in human prostate cancer cells Cancer Research
06/04/2012
Abstract 609: Benzyl isothiocyanate inhibits prostate cancer development in the transgenic adenocarcinoma mouse prostate model Cancer Research
06/04/2012
Abstract 607: Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea Cancer Research
06/04/2012
Abstract 606: Inhibitory effects of piceatannol on tumor angiogenesis and lung metastasis in the 4T1 mammary cancer model Cancer Research
06/04/2012
Abstract 604: The ginger compound, 6-shogaol, inhibits prostate cancer cell growth through reduced activation of signal transducer and activator of transcription 3 (Stat3) Cancer Research
06/04/2012
Abstract 603: Targeted Casp8AP2 methylation increased drug resistance in mesenchymal stem cell and cancer cells Cancer Research
06/04/2012
Abstract 600: EPA derived PGE3 inhibits proliferation and angiogenesis of non-small cell lung cancer A549 cells through the EGFR and MAPKinase pathways Cancer Research
06/04/2012
Abstract 597: Response of reactive oxygen species to eicosapentaenoic and calorie restriction in relation to mammary tumor prevention Cancer Research
06/04/2012
Abstract 596: Combination of SAHA with dietary energy restriction for breast cancer prevention Cancer Research
06/04/2012
Abstract 595: Non-motorized voluntary running does not affect experimental and spontaneous metastasis in mice Cancer Research
06/04/2012
Abstract 594: Effect of caloric restriction and high fat diet on azoxymethane-induced carcinogenesis in LETO and OLETF rats Cancer Research
06/04/2012
Abstract 590: Andrographolide suppresses prostate cancer cell migration and alters the expression of vimentin, ZO-1 and MMP-11 Cancer Research
06/04/2012
Abstract 588: Evidence for a role of a P2X7- EHBP1-Akt axis in prostate carcinogenesis and in statin chemo-prevention Cancer Research
06/04/2012
Abstract 587: Phenethyl isothiocyanate suppresses inhibitor of apoptosis family protein expression in prostate cancer cells in culture and in vivo Cancer Research
06/04/2012
Abstract 586: Withaferin-A inhibits prostate tumor growth by enhancing anti-tumor immune response Cancer Research
06/04/2012
Abstract 828: Src plays a role in chemoresistance and migration in chondrosarcoma cell lines Cancer Research
06/04/2012
Abstract 827: Development of stabilized homoglutathione disulfide as a novel nontoxic redox perturbing agent for increased anticancer efficacy Cancer Research
06/04/2012
Abstract 826: Yes-associated protein increases hepatocellular carcinoma chemosensitivity by modulating p53 Cancer Research
06/04/2012
Abstract 825: Wnt/beta-catenin signaling regulates the expression of O6-methylguanine DNA-methyltransferase in cancer cells: a new strategy to overcome resistance for DNA alkylators in cancer therapy Cancer Research
06/04/2012
Abstract 823: Integration of microRNA and gene expression signatures from several models of Docetaxel-resistant prostate cancer cell lines Cancer Research
06/04/2012
Abstract 820: Somatic mutations to identify tumors for highly selective chemosensitization by Nrf2 depletion Cancer Research
06/04/2012
Abstract 819: Chronic smoking increases tumorigenicity and imparts resistance to platinum-based chemotherapy partly by down-regulating Smad3 in non-small cell lung cancer Cancer Research
06/04/2012
Abstract 818: Targeting the redox-adaptive response in tumors to potentiate cancer therapy Cancer Research
06/04/2012
Abstract 817: Enhancement of paclitaxel and carboplatin therapy by CCL2 blockade in ovarian cancers Cancer Research
06/04/2012
Abstract 816: Functional analysis of miRNA in chemotherapy resistant neuroblastoma Cancer Research
06/04/2012
Abstract 815: The role of spleen tyrosine kinase (SYK) in paclitaxel resistant ovarian cancer Cancer Research
06/04/2012
Abstract 814: P-glycoprotein transport of the active imatinib metabolite, CGP74588, in chronic myeloid leukemia cells Cancer Research
06/04/2012
Abstract 813: Mechanism of cellular uptake of Pt drugs: The role of hCTR1 Cancer Research
06/04/2012
Abstract 812: Identification of novel anticancer drugs as substrates of organic anion transporting polypeptide 1B3 using a cell viability assay Cancer Research
06/04/2012
Abstract 811: VAL083, a novel N7 alkylating agent, surpasses temozolomide activity and inhibits cancer stem cells providing a new potential treatment option for glioblastoma multiforme Cancer Research
06/04/2012
Abstract 810: FBXO15 is an F-box protein in E3 ligase complex for P-glycoprotein Cancer Research
06/04/2012
Abstract 807: 5-AZA/TSA reverses tamoxifen induced changes in chromatin remodeling enzymes in MCF-7/TAM-R cells Cancer Research
06/04/2012
Abstract 806: Extracellular matrix metalloprotease inducer (EMMPRIN) and CD44 protein complexes are exclusively formed in basal- and normal-like breast cancer cell lines Cancer Research
06/04/2012
Abstract 805: The role of aldo-keto reductases and estrogen signalling in acquired anthracycline resistance Cancer Research
06/04/2012
Abstract 802: A key role for ARF in drug resistance in invasive bladder cancer Cancer Research
06/04/2012
Abstract 801: Comparison of cisplatin induced changes in serous ovarian cancer and normal fallopian tube cells Cancer Research
06/04/2012
Abstract 800: Formation of chemotherapy resistance-inducing fatty acids by mesenchymal stem cells depends on COX-1, thromboxane synthase and intracellular calcium Cancer Research
06/04/2012
Abstract 799: Comprehensive proteomic analysis of cisplatin resistance in ovarian cancer Cancer Research
06/04/2012
Abstract 798: Id1 (Inhibitor of differentiation-1) expression demonstrates important translational implications for pancreatic adenocarcinoma Cancer Research
06/04/2012
Abstract 797: Gemcitabine resistant pancreatic cancer cell lines acquire an invasive phenotype with characteristics of EMT Cancer Research
06/04/2012
Abstract 796: Novel mechanisms of drug resistance in leukemia cells associated with changes in HoxA9 and microRNA expression Cancer Research
06/04/2012
Abstract 794: The relevance of exosomes in prostate cancer and their potential to confer docetaxel resistance to secondary cells Cancer Research
06/04/2012
Abstract 793: Evolutionary therapy modeling for multidrug resistance: A novel concept of false drug Cancer Research
06/04/2012
Abstract 791: The predictive value of a novel miR-519c-HuR-ABCG2 regulatory pathway in chemoresistance of colorectal cancer Cancer Research
06/04/2012
Abstract 325: Splice isoform switching: A new mechanism controlling EMT and breast cancer progression Cancer Research
06/04/2012
Abstract 324: The integrin-linked kinase (ILK) / Rictor complex is required for TGF{beta}-1-induced epithelial to mesenchymal transition (EMT) Cancer Research
06/04/2012
Abstract 323: Targeting B-catenin/CBP interaction in basal like breast cancer and breast cancer stem cells Cancer Research
06/04/2012
Abstract 322: Functional significance of tyrosine phosphorylation of galectin-3 in prostate cancer progression Cancer Research
06/04/2012
Abstract 321: IL-6 in the tissue microenvironment plays a direct role in normal prostatic neoplastic transformation Cancer Research
06/04/2012
Abstract 320: Investigating the patterns of nuclear factor-kappa B activity in the host-tumor microenvironment during ovarian cancer progression Cancer Research
06/04/2012
Abstract 319: The mucin MUC16 protects ovarian cancer cells from innate immune responses Cancer Research
06/04/2012
Abstract 318: Microglia promote glioma cell migration through a Pyk2 signaling pathway Cancer Research
06/04/2012
Abstract 317: Colorectal cancers with microsatellite instability harbor an inflammatory microenvironment, different from the one observed in microsatellite stable colorectal cancers Cancer Research
06/04/2012
Abstract 315: Immune cells promote hepatocellular carcinoma stemness phenotype Cancer Research
06/04/2012
Abstract 314: The interaction between chronic alcohol consumption and melanoma skews the iNKT cell cytokine profile towards IL-4 dominance Cancer Research
06/04/2012
Abstract 313: K-ras- and EGFR-mediated lung tumor formation require epithelial NF-{kappa}B signaling to modulate the inflammatory microenvironment Cancer Research
06/04/2012
Abstract 312: Blockade of tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor overcomes tumor regrowth after radiotherapy Cancer Research
06/04/2012
Abstract 311: HER2/neu oncogene induced tumors in mammary epithelial cell COX-2 deficient mice have disease delaying modifications of tumor microenvironment Cancer Research
06/04/2012
Abstract 310: Oncogene-specific regulation of immune responses during tumorigenesis Cancer Research
06/04/2012
Abstract 308: Tumor hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells Cancer Research
06/04/2012
Abstract 306: TWEAK functions as chemotactic factor for glioma cells via Lyn activation Cancer Research
06/04/2012
Abstract 305: Modulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion and metastasis Cancer Research
06/04/2012
Abstract 304: Proinflammatory secretory chemokine CXCL8 regulates intercellular cross-talk in the breast cancer tumor microenvironment Cancer Research
06/04/2012
Abstract 303: Host-derived CCL2 plays a critical role in prostate cancer growth and skeletal metastasis Cancer Research
06/04/2012
Abstract 302: CCR5 and CCRL2 accommodating responses to CCL5 induces directional cancer cells migration and organ specific metastasis Cancer Research
06/04/2012
Abstract 301: Ccl17 and Ccr4 co-localize in mouse lung adenomas in vivo and are associated with epithelial cell migration in vitro Cancer Research
06/04/2012
Abstract 300: Blockage of OPN induction via HGF/cMET signaling in multiple myeloma cells suppresses both MMP9 expression and RUNX2 expression of BMSCs associating with bone erosion of MM patients Cancer Research
06/04/2012
Abstract 299: Modulation of the leptin receptor in pancreatic cancer cells mediates tumor growth Cancer Research
06/04/2012
Abstract 298: Tumor-associated lymphatic vessels: Hijacking mechanisms of peripheral tolerance Cancer Research
06/04/2012
Abstract 297: Effect of hypoxia on the expression of the T cell co-inhibitory ligands B7-H3 and B7-H1 in cancer Cancer Research
06/04/2012
Abstract 296: The expression and potential role of MUC7 in pancreatic adenocarcinoma Cancer Research
06/04/2012
Abstract 295: IDO drives tumor-promoting, pathogenic inflammation in lung Cancer Research
06/04/2012
Abstract 294: Sox2 remodels the tumor microenvironment via recruitment of Tregs Cancer Research
06/04/2012
Abstract 293: Tumor cell cross-talk with tumor-associated leukocytes leads to induction of tumor exosomal fibronectin and promotes tumor progression Cancer Research
06/04/2012
Abstract 292: Modulation of cyr61/ccn1 expression in human cell lines by the polyphenolic compound resveratrol Cancer Research
06/04/2012
Abstract 291: Vitamin D induces KDM6B/JMJD3 histone demethylase gene in human colorectal cancer cells Cancer Research
06/04/2012
Abstract 290: A Twist1 code of p53 inactivation Cancer Research
06/04/2012
Abstract 289: Hydrogen bond surrogate (HBS) helices as orthosteric regulator of hypoxia inducible transcription Cancer Research
06/04/2012
Abstract 288: Targeting Sp1 transactivation in Waldenstrom's macroglobulinemia: A novel therapeutic option Cancer Research
06/04/2012
Abstract 287: JUNB exhibits loss of "Paused" Pol II regulation and promotes survival in response to Flavopiridol in malignant MCF10CA1a cells Cancer Research
06/04/2012
Abstract 286: Development and evaluation of a molecular decoy against SLUG function in the breast cancer cells Cancer Research
06/04/2012
Abstract 285: Androgen receptor splice variants determine taxane sensitivity in prostate cancer Cancer Research
06/04/2012
Abstract 284: 17{beta}-estradiol-induced expression of {alpha}EF1 confers tamoxifen resistance in breast cancer Cancer Research
06/04/2012
Abstract 283: OOPs: Novel HIF-1{alpha} mimics Cancer Research
06/04/2012
Abstract 281: Novel nucleic acid constructs and formulations for treatment of bladder cancer and malignant ascites Cancer Research
06/04/2012
Abstract 280: Genetics and functions of Kaposi's sarcoma-associated herpesvirus (KSHV) glycoproteins in virion egress, infectivity and tumorigenesis Cancer Research
06/04/2012
Abstract 279: Small interfering RNA targeting CD44 blocks EGFR signaling in head and neck squamous cell carcinoma (HNSCC) Cancer Research
06/04/2012
Abstract 278: Post-transciptional activation of anti-oxidant enzymes by imatinib Cancer Research
06/04/2012
Abstract 277: The small molecule tolfenamic acid inhibits neuroblastoma cell growth through inducing apoptosis and causing cell cycle arrest potentially targeting Sp1 and survivin Cancer Research
06/04/2012
Abstract 276: Targeting signaling networks via RNAi to improve therapy for ovarian cancer Cancer Research
06/04/2012
Abstract 275: Enhancing the anticancer activity of pegylated interferon by dual specificity protein phsphatase 1 (DUSP1) silencing in hepatocellular carcinoma based replicon Cancer Research
06/04/2012
Abstract 274: The combined actions of DHT and MPA lead to altered AR signaling in normal and malignant post-menopausal breast epithelial cells Cancer Research
06/04/2012
Abstract 273: Transcriptional regulation of L1CAM in endometrial cancer Cancer Research
06/04/2012
Abstract 272: Nanoscale high-throughput quantitative RT-PCR for the characterization of targeted-therapy related molecular biomarkers from recurrent and non-recurrent NSCLC tissues Cancer Research
06/04/2012
Abstract 271: Validation of Polo-like Kinase 1 as a novel therapeutic target in alveolar rhabdomyosarcoma Cancer Research
06/04/2012
Abstract 270: Compensatory and non-compensatory alterations in LNCaP gene expression following antisense therapy directed against bcl-2 Cancer Research
06/04/2012
Abstract 269: A novel mechanism of p21 induction by oxaliplatin in p53 deficient cancer cells Cancer Research
06/04/2012
Abstract 268: Regulation of the UDP-glucuronosyltransferases (UGTs) by UV exposure in human melanocytes Cancer Research
06/04/2012
Abstract 267: Large-scale RNAi screening of human kinome identifies putative breast cancer related molecular targets Cancer Research
06/04/2012
Abstract 266: Angiotensin I-7 modulates transcriptional (de)activation of multiple members of steroid hormone receptor superfamily: Possible mechanisms underlying inhibited proliferation in (T47D) human breast cancer cells Cancer Research
06/04/2012
Abstract 265: STAT-1 activation enhances phospholipid scramblase 1-mediated apoptosis in aromatase inhibitor resistant breast cancer cells Cancer Research
06/04/2012
Abstract 264: ENC1, a BTB/Kelch protein, links DNA-damage signals to apoptosis by ubiquitination of retinoblastoma protein Cancer Research
06/04/2012
Abstract 263: Silence of SOX2 induces apoptosis through both mitochondria and death receptor signal pathway by activating the RAS/MAPK signals in human lung cancer cells Cancer Research
06/04/2012
Abstract 262: O6-methylguanine:Deoxythymidine mismatches sensitize cells to DNA strand break-induced cytotoxicity Cancer Research
06/04/2012
Abstract 261: The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition Cancer Research
06/04/2012
Abstract 260: FK506 binding protein (FKBP) 51 controls "TNF-related apoptosis inducing ligand" (TRAIL) response in melanoma Cancer Research
06/04/2012
Abstract 259: Antitumor activities of yuanhuadine, a daphnane diterpene from Daphne genkwa, via epidermal growth factor receptor signaling in non-small cell lung cancer cells Cancer Research
06/04/2012
Abstract 258: Development of death receptor agonists - A novel therapy for breast cancer Cancer Research
06/04/2012
Abstract 256: Involvement of ERK and ROS in CLEFMA-induced apoptosis in lung cancer cells Cancer Research
06/04/2012
Abstract 255: Identification of a novel TRAIL sensitizer in TRAIL-resistant cancer cells Cancer Research
06/04/2012
Abstract 254: Genome-wide shRNA screening identifies candidate proteins modulating the extrinsic apoptotic pathway Cancer Research
06/04/2012
Abstract 253: The cancer testis antigen MAGED2 protects human melanoma cells from TRAIL-induced apoptosis by suppressing TRAIL-R2 expression Cancer Research
06/04/2012
Abstract 252: Altered caspase-8 localization and decreased caspase-8 sumoylation in TRAIL-resistant normal human fibroblasts Cancer Research
06/04/2012
Abstract 251: Role of ss-catenin in prostate cancer cell apoptosis Cancer Research
06/04/2012
Abstract 250: Apoptosis-associated genes related to photodynamic therapy in breast carcinomas Cancer Research
06/04/2012
Abstract 249: The role of cholesterol in ultraviolet light B-induced apoptosis Cancer Research
06/04/2012
Abstract 248: JNK-FoxO3a dependent apoptosis in quercetin treated MDA-MB-231 human breast cancer cells Cancer Research
06/04/2012
Abstract 247: Aldose reductase inhibition sensitizes colon cancer cells to TRAIL-induced apoptosis Cancer Research
06/04/2012
Abstract 246: Calmodulin binding to death receptor-5 regulates pancreatic cancer apoptosis Cancer Research
06/04/2012
Abstract 245: ST6Gal-I sialylation of the Fas (CD95) receptor provides protection against Fas mediated apoptosis Cancer Research
06/04/2012
Abstract 244: Characterization of a candidate tumor suppressor gene DIRAS1 in esophageal squamous cell carcinoma Cancer Research
06/04/2012
Abstract 243: Overcoming resistance to cisplatin in NSCLC cell lines: TRAIL-modulating strategy by a DR5 agonist, LBY135 Cancer Research
06/04/2012
Abstract 242: Anti-obesity drugorlistat enhances sensitivity toTRAIL by two different pathways inhormone-refractory prostate cancer cells Cancer Research
06/04/2012
Abstract 241: A novel function of thyroid hormone receptors in promoting metastasis of human hepatoma cells via regulation of TRAIL Cancer Research
06/04/2012
Abstract 240: Transcriptional knockdown of urokinase-type plasminogen activator receptor (uPAR) induces apoptosis in glioblastoma xenograft cells via activation of p53 Cancer Research
06/04/2012
Abstract 239: A novel multimeric protein scaffold stimulates apoptotic signaling through TRAILR2 Cancer Research
06/04/2012
Abstract 238: Role of GSK3{beta} in modulating TRAIL-induced apoptosis in prostate cancer cells Cancer Research
06/04/2012
Abstract 237: Novel applications of pSIVA, a new polarity sensitive phosphatidylserine (PS) apoptosis/cell death probe Cancer Research
06/04/2012
Abstract 236: Characterizing cellular signal transduction cross-talk using in-cell kinase screen Cancer Research
06/04/2012
Abstract 235: Expression of DUSP4/MKP2 increases cell growth in colorectal cancer (CRC) cells and is associated with MSI-H phenotype in CRC Cancer Research
06/04/2012
Abstract 234: Snapshot of MAP kinase and related signal transduction pathways from biopsied cells using a novel non-optical assay technology - a proof of concept study Cancer Research
06/04/2012
Abstract 233: Polo-like kinase 1 facilitates loss of Pten-induced prostate cancer formation Cancer Research
06/04/2012
Abstract 232: Protein kinase C b1 (PKCb1) inhibits the malignant phenotype of the human pancreatic tumor-derived cell line PANC1 Cancer Research
06/04/2012
Abstract 231: Development of an ELISA for quantification of in vitro and cellular PTEN phosphatase activity Cancer Research
06/04/2012
Abstract 230: A novel quantitative phosphoproteomic approach in mouse xenograft models to identify Src oncogenic signaling in colorectal cancer Cancer Research
06/04/2012
Abstract 229: Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase non-receptor type 14 Cancer Research
06/04/2012
Abstract 228: PAK1 kinase promotes cell motility through CRK serine phosphorylation in non-small cell lung cancer cells Cancer Research
06/04/2012
Abstract 227: Overexpression of EphB1 leads to Stat3 phosphorylation Cancer Research
06/04/2012
Abstract 226: The focal adhesion kinase is phosphorylated on serine732 by a Growth factor-dependent pathway and contributes to the proliferation of tumor cells Cancer Research
06/04/2012
Abstract 225: Protein tyrosine kinase 6 directly phosphorylates p130 CRK-associated substrate to promote peripheral adhesion complex formation and cell migration Cancer Research
06/04/2012
Abstract 224: TOPK phosphorylation of MKP1 prevents solar ultraviolet irradiation-induced inflammation by inhibiting p38 signaling Cancer Research
06/04/2012
Abstract 223: Oncogenic resistance of Akt kinases to dephosphorylation through an ATP-dependent molecular switch Cancer Research
06/04/2012
Abstract 222: NEK6 promotes JB6 C141 cell transformation and activates STAT3 through its phosphorylation on Ser727 Cancer Research
06/04/2012
Abstract 221: p21-activated kinase 1 (Pak1) phosphorylates BAD directly at serine 111 in vitro and indirectly through Raf-1 at serine 112 Cancer Research
06/04/2012
Abstract 220: TNF{alpha} activates NF-{kappa}B through RIP1 ubiquitination-dependent and independent pathways Cancer Research
06/04/2012
Abstract 218: The hexosamine biosyntheic pathway and O-linked glycosylation for targeted therapy in diffuse large B-cell lymphoma Cancer Research
06/04/2012
Abstract 217: Modulation of Hsp90 chaperone activity by hypoxic condition: Hypoxia stimulates ARD1-mediated Hsp90 post-translational modification Cancer Research
06/04/2012
Abstract 216: Novel assays for Sirtuin and PARP families utilizing unmodified substrates Cancer Research
06/04/2012
Abstract 215: Mechanisms of p53 activation by NIAM, nuclear interactor of ARF and MDM2 Cancer Research
06/04/2012
Abstract 214: High expression of CKS1B antagonizes MLN4924, a nedd8-activating enzyme inhibitor, that induces myeloma cell growth inhibition through decreased neddylation of SCF complex Cancer Research
06/04/2012
Abstract 213: RNF126 E3 ubiquitin ligase targets p21cip for ubiquitin-mediated degradation Cancer Research
06/04/2012
Abstract 212: gp78/AMFR is involved in ubiquitination of PGI/AMF Cancer Research
06/04/2012
Abstract 211: Ubiquitin-proteolytic regulation of hematopoietic stem cell expansion Cancer Research
06/04/2012
Abstract 210: Cul4A is an oncogene in malignant pleural mesothelioma Cancer Research
06/04/2012
Abstract 209: Identification of {beta}-catenin lysine 394 as a novel charge button and ubiquitination site by Rad6B Cancer Research
06/04/2012
Abstract 208: The MAGE family of cancer-testis antigens are potent oncogenes Cancer Research
06/04/2012
Abstract 207: Casitas B-lineage lymphoma-3 is an epigenetically regulated gene whose knockdown induces mesenchymal to epithelial transition and enhances erlotinib sensitivity in lung cancer cell lines Cancer Research
06/04/2012
Abstract 206: A single nucleotide polymorphism (SNP) rs35301225 (A/C/T) in pre-miR-34a alters the cell cycle regulation Cancer Research
06/04/2012
Abstract 205: The three-throng role of miR-21 in cancer Cancer Research
06/04/2012
Abstract 416: Radiation-induced reprograming of breast cancer cells Cancer Research
06/04/2012
Abstract 414: Role of stem cell marker, nestin in human uterine cervical intraepithelial neoplasia and cervical cancer Cancer Research
06/04/2012
Abstract 413: Genome-wide microarray expression and array-CGH analysis in neuroblastoma stem-like cells by use of the neurosphere-formation assay Cancer Research
06/04/2012
Abstract 412: Expression of cancer stem cell markers in pancreatic ductal adenocarcinomas and pancreatic intraepithelial neoplasias Cancer Research
06/04/2012
Abstract 411: PI3 Kinase gamma control of Arginase-1 expression promotes tumor immunosuppression Cancer Research
06/04/2012
Abstract 410: NLRP3 is involved in tumor development by regulating immune function Cancer Research
06/04/2012
Abstract 409: Bacterial protein AvrA targets intestinal stem cells via beta-catenin pathway and enhances intestinal tumorigenesis Cancer Research
06/04/2012
Abstract 408: Intermittent hypoxia effect on osteoclastogenesis stimulated by neuroblastoma cells Cancer Research
06/04/2012
Abstract 407: Loss of Smad3 alters host-microbial interactions, predisposing the colonic epithelium to inflammation Cancer Research
06/04/2012
Abstract 406: Monitoring inflammation and therapeutic response with clinically translational 19F MRI Cancer Research
06/04/2012
Abstract 405: Innate immunity in taxol-mediated tumor regression Cancer Research
06/04/2012
Abstract 403: Interaction of carbon nanotubes with macrophages in tumor microenvironment Cancer Research
06/04/2012
Abstract 402: Plasticity of tumor associated macrophages in a metastatic melanoma model in the mouse Cancer Research
06/04/2012
Abstract 401: Early immune modulatory events during ovarian cancer outgrowth in the omental fat band Cancer Research
06/04/2012
Abstract 400: A new model for macrophage transdifferentiation into lymphatic endothelial cell progenitors Cancer Research
06/04/2012
Abstract 399: Deletion of the Mint3 gene in mice abrogates macrophage functions and increases resistance to cancer metastasis Cancer Research
06/04/2012
Abstract 398: Tumor microenvironment imposes major alterations and profoundly shapes functional status of macrophages: peritoneal and tumor-associated macrophages from tumor hosts are two very different subpopulations Cancer Research
06/04/2012
Abstract 397: Soluble Tumor Necrosis Factor Receptor shed by breast tumor cells modulates macrophage migration Cancer Research
06/04/2012
Abstract 396: Sequential metastases of colorectal cancer: Treatment, immunophenotypes and spatial distributions of infiltrating immune cells Cancer Research
06/04/2012
Abstract 395: Host ephrinB2 regulates T-cells in tumor microenvironments Cancer Research
06/04/2012
Abstract 394: Close association between subsided inflammation and the development of histologically less malignant HCC in HCV-associated LC Cancer Research
06/04/2012
Abstract 393: Low-dose gamma-irradiation inhibits IL-6 secretion from human lung fibroblasts to suppress bronchial epithelial cell transformation by cigarette smoke carcinogen Cancer Research
06/04/2012
Abstract 391: Serum ferritin predicts response to trastuzumab and is a biomarker for breast and pancreatic cancers: A potential novel inflammatory effector mechanism Cancer Research
06/04/2012
Abstract 389: MMP12 and myeloid cell populations influence establishment of tumor metastases in the steatotic liver microenvironment Cancer Research
06/04/2012
Abstract 388: mS100a7a15 enhances mammary tumor growth and metastasis by recruiting tumor associated macrophages Cancer Research
06/04/2012
Abstract 385: Potentiating MUC1 expression in human bronchial epithelial cells by cigarette smoke carcinogens through induction of TNF-{alpha} secretion from macrophages Cancer Research
06/04/2012
Abstract 384: CD14+S100A9 high monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer Cancer Research
06/04/2012
Abstract 382: In-vivo imaging of lung cancer using tumor homing peptide coated nanoparticles Cancer Research
06/04/2012
Abstract 381: Non-invasive histology for early detection of cutaneous melanoma and pigmented lesions in vivo Cancer Research
06/04/2012
Abstract 380: Optimization of novel therapeutic paradigms for ovarian cancer using molecular imaging Cancer Research
06/04/2012
Abstract 378: Multifunctional bladder cancer targeting micelle nanocarriers with both imaging and therapeutic potentials Cancer Research
06/04/2012
Abstract 377: Organic Anion Transporting Polypeptides (OATPs): A potential new molecular target for imaging/therapy of hormone dependent breast cancers Cancer Research
06/04/2012
Abstract 376: Limits of [18F]-FLT PET as a predictive imaging biomarker of proliferation in oncology Cancer Research
06/04/2012
Abstract 375: Fluorescence-guided surgery leads to improved resection of primary pancreatic cancer and prolonged survival Cancer Research
06/04/2012
Abstract 373: Oligonucleotide aptamer: A promising imaging probe for CD30-positive lymphoma tumors Cancer Research
06/04/2012
Abstract 371: In vivo monitoring of metabolic inhibition in anaplastic thyroid carcinoma Cancer Research
06/04/2012
Abstract 370: Tetrazine trans-cyclooctene ligation: An efficient 18F labeling method for cysteine containing peptides and proteins Cancer Research
06/04/2012
Abstract 369: Tumor detection and surgical navigation with fluorescence laparoscopy is enhanced with combinations of differently labeled fluorophore-conjugated antibodies and fluorescent proteins Cancer Research
06/04/2012
Abstract 368: Development of a highly potent and non-invasive optical imaging agent for glioblastoma Cancer Research
06/04/2012
Abstract 367: Imaging and diagnostic potentials of a novel cancer targeting peptide on bladder cancer in vitro and in vivo Cancer Research
06/04/2012
Abstract 366: Enhanced tumor detection of fluoroscence laparoscopy improves laparoscopic resection of primary pancreatic cancer in mouse models Cancer Research
06/04/2012
Abstract 365: DNA double-strand break imaging with anti-{gamma}H2AX antibodies does not alter DNA repair kinetics Cancer Research
06/04/2012
Abstract 364: In vivo targeting of CD44+ ovarian cancer stem cells (CSC) by Clostridium Perfringens Enterotoxin binding domain (CPE-peptide) conjugated to poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NP) Cancer Research
06/04/2012
Abstract 363: Development of computer-aided detection (CAD) tool for liver metastasis micro CT imaging using targeted contrast agent Cancer Research
06/04/2012
Abstract 362: [18F]-FLT Positron Emission Tomography can be used to image the response of sensitive tumours to PI3-Kinase inhibition with the novel agent GDC-0941. Cancer Research
06/04/2012
Abstract 361: PET imaging of antitumor responses with anti-4-1BB (anti-CD137) Cancer Research
06/04/2012
Abstract 360: Tumor specific imaging by L-5-F-18-ethoxy-Tryptophan mediated by LAT1 and IDO1 Cancer Research
06/04/2012
Abstract 359: Longitudinal monitoring of autotaxin-expressing tumors in vivo using an activatable near-infrared fluorescent probe Cancer Research
06/04/2012
Abstract 358: The novel sentinel lymphnodes identification method using magnetic nanoparticle by MRI Cancer Research
06/04/2012
Abstract 357: Nonclinical tumor efficacy studies of [18F]AH113804, a novel PET imaging agent with high affinity for the human c-Met receptor Cancer Research
06/04/2012
Abstract 356: Photoacoustic imaging of pancreatic cancer proliferation via sigma-2 receptor/PGRMC1-eYFP Cancer Research
06/04/2012
Abstract 355: Comparison of biodistribution and accumulation of a thermally responsive polypeptide with and without a cell-penetrating peptide Cancer Research
06/04/2012
Abstract 354: Monitor androgen blockade therapy with functional androgen receptor reporting system Cancer Research
06/04/2012
Abstract 353: In vivo PET imaging of HER2 expression with GE226: An 18F-labelled affibody molecule Cancer Research
06/04/2012
Abstract 352: hnRNP A2/B1 regulates S1PR3 expression in lung cancer Cancer Research
06/04/2012
Abstract 350: Claudin 1 expression in the basal-like breast cancer subtype (BLBC) is age related and higher in postmenopausal women Cancer Research
06/04/2012
Abstract 349: Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires {beta}-catenin activation via Akt/GSK3-dependent and MTA1/Wnt1-dependent pathways Cancer Research
06/04/2012
Abstract 348: Extracellular heat shock protein 90 (eHsp90) initiates EMT events and enhances cell motility in prostate cancer Cancer Research
06/04/2012
Abstract 347: The role of the epithelial-mesenchymal transition in the maintenance of stemness in neural and glioma stem cells Cancer Research
06/04/2012
Abstract 345: Circulating tumor cells from perfusable tumor nodules grown on decellularized rat lung scaffold has mesenchymal characteristics Cancer Research
06/04/2012
Abstract 344: Mifepristone alters morphology, cytoskeletal architecture, and epithelial-mesenchymal transition-related proteins in human metastatic cancer cells Cancer Research
06/04/2012
Abstract 343: Inhibitory effect of oncolytic adenovirus on transforming growth factor- {beta}-induced epithelial-mesenchymal transition in human cancer cells Cancer Research
06/04/2012
Abstract 342: Silencing of IGF1R induces mesenchymal-to-epithelial transition and inhibits the metastatic properties of triple negative breast cancer cells Cancer Research
06/04/2012
Abstract 341: Loss of DAB2IP promotes colorectal cancer progression by inducing epithelial-mesenchymal transition and cancer stem-like cell signatures Cancer Research
06/04/2012
Abstract 340: MT1-MMP triggers an epithelial to mesenchymal transition program via activation of a TGF-{beta} signaling pathway leading to Wnt5a induction Cancer Research
06/04/2012
Abstract 339: Apricoxib, a selective COX-2 inhibitor, suppresses IL-27-mediated STAT3 activation and potentiates its inhibition of epithelial to mesenchymal transition in human non-small cell lung cancer Cancer Research
06/04/2012
Abstract 337: Expression of claudin-7 in colon cancer cells induces mesenchymal to epithelial transition (MET) and inhibits tumorigenesis Cancer Research
06/04/2012
Abstract 336: 4-methylumbeliferone, an HA synthesis inhibitor, inhibits EMT determinants in bladder cancer cell lines Cancer Research
06/04/2012
Abstract 335: Human neuroblastoma cells undergo TGF-beta mediated mesenchymal change in the transition to drug resistance Cancer Research
06/04/2012
Abstract 334: Identification of novel regulatory genes controlling epithelial to mesenchymal transition in cultured breast cancer cells Cancer Research
06/04/2012
Abstract 333: SFRP4 modulates EMT, cell migration and downstream Wnt signalling in epithelial ovarian cancer. Cancer Research
06/04/2012
Abstract 332: The role of OLA1, a novel obg-like ATPase, in epithelial-mesenchymal transition Cancer Research
06/04/2012
Abstract 331: Epithelial-mesenchymal transition confers resistance to complement-dependent cytotoxicity in lung cancer cells Cancer Research
06/04/2012
Abstract 329: Downregulation of PKCisin/par3/par6 polarity complex is critical for hypoxia-induced epithelial-mesenchymal transition, migration, and invasion in lung cancer cells Cancer Research
06/04/2012
Abstract 328: The mitotic kinase Aurora-A promotes breast cancer metastases by inducing a CD24low/- basal-like stem cell phenotype Cancer Research
06/04/2012
Abstract 327: Properties associated with cancer progression in primary clonal epithelial and mesenchymal-like murine mammary tumor cells Cancer Research
06/04/2012
Abstract 326: Aneuploidy-driven clonal diversification underlies tumor phenotype switching Cancer Research